hg_58845.1

Basic information about the TSS

---

TSS ID: hg_58845.1 Species: human Chr: chr5		Start: 139561404 End: 139561418 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AY651263 Distance: 0 GeneID: 7322 HGNC/MGI_ID: HGNC:12475 UniProt_ID:

Gene_name: ubiquitin conjugating enzyme E2 D2 Gene_symbol: UBE2D2 Gene_synonyms: UBC4 UbcH5B Gene_source: HGNC:12475

TATA-Box annotation

---

Distance to TSS:	72
Nearest PromoterID:	NM_003339
Entrez ID:	7322
Nearest Unigene:	Hs.108332
Nearest Refseq:	NM_003339
Nearest Ensembl:	ENSG00000131508
Gene Name:	ubiquitin conjugating enzyme E2 D2
Gene Alias:	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B
Gene Description:	ubiquitin conjugating enzyme E2 D2
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2D2 p2@UBE2D2 p3@UBE2D2 p4@UBE2D2 p5@UBE2D2 p6@UBE2D2 p7@UBE2D2 p8@UBE2D2 p9@UBE2D2 p10@UBE2D2
Sample		p1@UBE2D2	p2@UBE2D2	p3@UBE2D2	p4@UBE2D2	p5@UBE2D2	p6@UBE2D2	p7@UBE2D2	p8@UBE2D2	p9@UBE2D2	p10@UBE2D2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	83.96	77.34	18.12	6.62	18.12	1.36	0.58	4.48	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	88.62	80.52	20.84	5.87	16.39	2.23	1.01	2.83	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	84.11	83.33	23.53	8.87	14.08	2.51	0.00	3.47	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	66.53	66.53	22.04	6.65	13.72	0.42	0.62	2.29	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	70.19	81.44	19.57	6.75	17.55	2.02	0.67	2.92	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	66.86	66.48	24.61	9.30	14.73	1.55	0.39	3.88	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	117.00	88.02	31.81	10.02	22.01	3.27	0.87	6.10	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	104.88	87.44	26.89	9.45	19.38	3.15	0.73	6.78	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	113.27	104.51	26.71	13.04	23.51	1.50	1.71	6.41	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	83.47	77.09	20.87	11.01	28.98	1.16	0.00	6.38	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.51	90.95	25.87	17.79	31.93	1.21	0.40	6.87	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	84.56	107.74	21.55	16.67	34.96	1.22	1.22	6.10	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	67.06	40.94	1.45	3.55	1.13	1.61	1.77	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	51.42	32.78	1.05	0.90	0.90	1.80	0.45	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.06	44.13	1.54	2.85	1.76	1.98	2.42	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	57.59	31.69	0.75	2.77	1.01	2.01	0.50	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	48.92	33.42	0.44	1.31	1.53	2.40	0.87	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	56.95	26.57	2.53	2.53	1.69	0.42	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	51.72	25.59	0.53	2.67	0.53	1.07	1.60	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	63.03	46.34	2.86	2.41	1.35	1.50	2.56	0.45	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	73.64	40.23	2.27	3.07	2.00	1.60	2.94	0.53	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	59.90	34.52	1.73	3.11	2.07	1.55	2.24	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.21	33.48	2.07	1.81	1.68	1.94	1.42	0.13	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	60.42	40.28	2.43	0.97	1.70	2.18	1.94	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	67.85	39.47	3.35	3.35	2.06	2.06	1.55	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	68.37	42.41	4.11	1.90	1.27	1.90	1.58	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	54.95	31.32	4.95	1.10	1.65	2.20	1.65	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	60.59	44.56	4.72	4.48	1.18	1.89	2.36	0.94	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	84.48	49.43	4.36	2.91	2.26	1.62	3.55	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	60.62	43.79	4.16	3.44	2.71	1.45	2.53	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	63.22	40.19	1.88	1.88	3.35	2.30	2.30	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	74.05	47.28	3.91	4.30	2.15	1.95	1.76	0.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	90.95	46.85	4.22	2.32	2.95	0.84	1.69	0.63	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	55.25	33.65	3.46	0.99	2.80	1.98	2.80	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	58.15	46.93	3.18	3.93	2.80	1.50	3.93	0.37	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	60.17	51.93	3.45	4.60	4.41	1.34	1.53	0.57	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	62.13	54.98	2.04	5.11	2.45	1.23	1.23	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	60.24	41.91	4.84	5.64	2.82	2.22	1.21	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.38	47.27	3.51	3.24	0.54	1.89	1.08	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	53.53	53.29	3.84	3.60	2.16	2.64	1.92	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	53.87	51.99	4.94	2.59	2.12	1.65	1.41	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.46	37.33	3.51	3.22	2.49	1.61	1.32	0.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	41.34	45.13	3.16	5.48	3.16	2.11	2.32	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	52.80	53.32	5.94	3.15	3.85	1.40	2.10	0.35	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.76	52.60	4.22	6.22	2.21	2.61	1.41	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.13	53.04	3.49	3.95	2.33	2.33	2.33	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	52.78	45.10	2.40	6.24	3.36	1.44	2.40	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	48.88	48.88	3.58	4.17	5.96	1.79	2.98	1.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	61.04	57.69	2.15	5.74	4.07	0.72	1.68	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.54	47.72	3.03	4.04	4.04	2.22	1.62	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	37.10	35.66	3.07	2.66	3.69	1.84	1.64	0.61	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	53.37	57.59	5.34	3.34	3.56	0.67	2.22	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	69.96	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	42.94	41.52	1.77	3.55	3.19	0.35	2.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.14	37.78	2.65	5.63	1.66	3.65	0.66	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	40.27	40.27	1.68	0.00	0.00	0.84	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	38.12	33.52	1.84	1.38	1.38	0.92	0.46	0.46	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.85	31.76	2.92	3.24	3.24	2.27	0.65	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.40	36.93	3.21	5.78	2.57	1.28	0.00	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.18	33.00	4.71	1.89	1.26	1.57	2.51	0.94	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	36.66	2.82	4.23	2.82	0.71	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	41.50	37.57	0.56	5.05	1.68	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	36.62	69.26	2.39	7.17	3.98	1.59	0.00	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.47	44.51	5.10	3.40	1.36	1.36	1.36	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	35.09	59.14	2.60	6.17	2.60	0.97	0.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	49.70	44.37	0.71	3.55	2.13	2.84	0.00	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	48.49	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	31.59	7.90	0.00	7.90	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	61.91	33.64	2.44	0.98	0.98	0.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	63.97	31.24	1.49	2.48	0.00	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	53.01	32.84	2.81	1.88	0.47	1.88	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	51.33	27.49	4.97	2.32	0.99	2.32	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	61.25	30.62	2.17	4.64	1.86	1.86	0.62	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	73.38	36.08	4.59	2.75	0.61	2.14	0.92	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	44.03	22.49	2.69	1.90	0.63	1.90	0.95	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	39.63	21.02	1.93	2.57	1.60	1.76	0.48	0.32	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	38.93	21.76	3.05	1.15	1.65	1.40	0.38	0.38	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	47.09	23.17	2.99	2.24	1.49	0.75	0.00	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	47.56	30.14	2.34	2.68	2.34	1.34	0.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	50.40	23.61	0.64	2.55	1.91	1.28	0.64	0.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	34.08	32.99	0.00	2.20	1.10	0.00	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	47.87	21.23	0.45	0.90	0.45	2.71	2.26	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	38.75	33.71	0.87	2.61	1.22	0.70	3.30	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	76.86	59.06	3.52	3.13	1.76	0.78	2.15	0.78	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	40.67	41.44	2.32	2.57	0.51	1.03	1.03	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	56.03	48.23	2.51	3.35	0.84	1.39	1.95	1.95	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	49.38	49.96	2.94	2.35	1.76	2.35	1.76	2.35	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	62.82	45.36	4.58	2.90	2.09	1.69	1.85	0.56	0.48	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	52.61	34.86	4.20	1.29	1.29	1.61	0.32	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	27.19	2.13	4.27	1.07	1.07	2.13	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	50.08	31.72	3.34	2.23	1.67	0.56	2.78	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	60.72	36.18	3.33	3.74	2.91	5.41	2.50	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	46.21	35.16	4.02	1.26	1.51	1.26	1.00	0.75	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	37.96	34.36	4.25	2.95	0.98	0.33	1.64	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	43.23	34.41	2.44	0.00	1.83	1.22	0.61	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	127.74	54.14	10.83	2.87	4.86	1.10	0.22	1.55	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	159.21	60.96	7.53	3.23	2.51	0.36	0.36	0.72	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	76.67	45.52	1.20	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	87.43	44.44	6.30	2.52	1.26	1.26	1.80	0.90	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	68.61	61.92	1.67	1.67	0.00	0.00	0.00	6.69	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	93.68	39.86	4.31	3.08	1.64	2.26	2.47	1.03	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	63.39	31.47	1.49	1.49	0.80	4.00	1.83	0.57	0.34	0.00
Anulus Pulposus Cell, donor2	11463-119B5	61.23	29.14	0.98	1.71	1.96	3.92	5.14	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	47.63	25.61	2.70	0.90	2.70	3.15	2.25	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.93	24.31	6.51	1.30	1.30	1.30	2.60	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	40.66	23.54	0.00	2.14	2.14	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	49.32	26.60	3.59	1.20	1.49	1.49	0.90	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	26.56	6.32	2.53	3.79	5.06	2.53	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.70	23.76	3.30	0.66	1.98	1.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	50.68	25.67	2.92	0.97	1.62	3.25	1.62	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	51.94	25.24	3.40	2.43	0.49	0.97	1.94	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	29.10	18.41	2.38	2.97	1.19	1.19	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	45.20	22.97	4.14	3.01	2.26	3.01	1.13	0.38	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	43.54	26.85	2.90	0.73	1.45	0.73	2.18	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	33.85	22.57	2.51	0.00	0.00	0.00	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.29	26.03	3.79	2.31	2.97	2.47	1.48	1.32	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	38.21	25.93	1.36	0.00	5.46	4.09	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.01	25.03	3.47	1.96	2.11	1.81	0.45	0.60	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	45.54	24.65	3.75	3.75	2.14	3.21	1.61	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.01	38.16	3.59	2.27	0.94	2.46	2.27	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.63	24.32	1.60	1.60	2.14	1.87	1.07	1.34	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	44.87	19.51	0.98	0.98	0.98	2.93	1.95	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	53.90	31.85	4.64	1.49	2.99	2.99	2.16	1.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	13.21	6.00	1.20	1.20	3.60	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	31.86	3.54	3.54	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.80	33.96	3.95	2.40	1.89	1.89	1.72	0.00	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	12.58	4.19	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	48.06	26.21	2.43	1.46	1.46	3.40	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	56.54	31.87	3.79	1.90	2.28	2.66	1.52	1.52	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	10.90	1.21	0.00	1.21	1.21	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	56.43	25.08	3.42	1.71	2.28	3.99	1.71	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	45.11	29.93	4.92	2.35	1.92	2.14	1.92	0.86	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.20	27.36	2.58	2.06	1.81	2.32	1.81	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	43.17	25.81	2.35	2.82	0.94	1.88	1.41	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	47.91	29.58	1.61	3.22	0.96	0.32	0.96	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	42.09	24.26	1.43	0.71	1.43	0.71	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	42.70	26.32	3.51	2.92	1.75	2.92	2.34	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	45.16	34.92	2.11	2.71	2.11	3.31	2.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	42.77	26.14	0.00	0.00	1.19	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	51.87	26.95	1.53	0.51	0.51	2.03	1.02	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	49.92	24.45	2.55	2.29	1.78	2.04	2.29	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	28.59	29.86	3.18	2.54	1.27	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	56.53	21.58	2.16	2.59	1.73	0.00	1.29	1.29	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	48.90	30.06	2.54	1.27	1.91	2.54	2.54	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	33.35	27.55	1.16	2.61	2.61	1.45	0.87	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	46.29	33.07	0.00	0.00	0.94	1.89	4.72	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	44.42	31.87	2.20	2.37	2.20	2.03	1.53	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	32.43	2.32	0.00	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	33.80	4.23	0.00	4.23	2.11	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.60	32.16	4.07	2.14	1.29	2.79	2.14	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	24.07	2.41	1.20	3.01	1.20	1.20	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	37.18	24.06	5.10	0.00	2.92	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	42.07	34.71	4.37	2.30	2.53	2.53	1.38	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	22.95	2.55	0.00	2.55	7.65	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.75	23.39	2.03	2.03	1.27	1.53	0.76	0.25	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	48.51	34.68	4.34	1.03	2.27	2.06	1.86	1.24	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	40.39	24.48	3.37	2.75	1.22	0.61	1.22	0.00	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	48.76	26.29	4.30	0.48	2.87	3.82	2.39	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	39.91	36.37	1.33	2.66	3.10	1.77	1.55	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	22.89	1.53	0.00	4.58	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	35.45	22.71	6.09	0.55	1.11	0.55	1.66	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.95	31.78	4.50	1.06	2.38	3.18	0.79	0.79	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	28.71	21.08	1.45	2.91	2.54	1.45	1.09	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	133.50	69.39	5.53	2.09	3.81	1.84	1.11	1.11	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	109.20	68.12	4.96	2.23	2.91	1.37	2.40	0.86	0.86	0.00
Astrocyte - cerebellum, donor3	11661-122F5	73.41	59.36	3.99	4.40	3.36	1.05	1.26	0.84	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	120.61	57.17	3.14	2.44	3.49	2.79	2.44	2.09	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	130.23	57.27	7.28	3.72	1.94	2.75	1.46	2.26	0.97	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	138.87	72.94	3.58	4.77	2.83	2.09	1.94	1.79	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	177.88	97.25	26.72	11.58	11.35	1.49	1.83	2.41	0.00	13.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	179.15	107.24	23.55	13.41	16.41	3.38	2.00	2.38	0.75	10.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	182.87	94.91	28.68	11.27	13.20	2.73	1.25	2.50	0.34	17.64
Basophils, donor1	12241-129G9	27.98	91.27	0.26	3.66	3.66	0.52	0.52	0.26	0.26	0.00
Basophils, donor2	12242-129H1	40.77	77.57	2.53	3.97	3.61	0.72	0.36	0.00	0.00	0.00
Basophils, donor3	12243-129H2	42.92	81.88	1.32	3.82	4.26	0.59	1.03	0.73	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	106.29	49.16	5.17	1.08	1.08	0.43	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	125.27	57.61	8.69	1.37	1.83	0.46	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	28.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.07	15.06	5.02	1.88	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	72.16	19.55	5.61	0.42	2.29	1.46	0.62	0.21	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	67.48	31.09	2.07	0.92	0.69	0.46	0.92	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	88.71	46.25	2.16	1.08	0.90	0.90	0.36	0.36	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	139.95	98.42	14.94	12.57	10.82	4.23	1.96	2.89	0.21	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	119.48	66.38	11.88	6.29	4.66	3.49	1.16	1.16	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	67.79	96.25	4.48	4.48	6.08	5.44	4.16	1.60	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	124.10	0.00	0.00	10.34	0.00	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	38.32	81.72	1.13	5.07	1.13	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	46.21	101.15	0.93	5.57	6.50	0.37	1.11	0.37	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	43.69	113.50	1.10	5.49	5.27	0.22	2.20	1.10	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	71.61	55.76	1.42	2.26	0.85	2.55	2.55	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	58.76	58.76	1.90	3.03	0.76	1.90	1.52	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	73.97	73.31	0.66	2.63	0.99	1.64	1.97	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	33.10	71.26	1.16	6.07	3.32	0.58	0.72	1.59	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	28.36	64.87	1.51	2.72	4.22	0.91	1.81	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	33.40	68.94	0.95	6.40	3.08	0.24	1.18	0.71	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.42	55.74	1.34	6.36	2.34	0.33	0.50	1.34	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.36	57.96	1.10	4.97	1.66	0.28	1.10	0.55	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.27	61.73	1.49	3.22	2.23	0.74	1.24	1.74	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.89	82.04	1.17	4.90	1.96	0.39	0.98	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	20.30	54.84	0.71	2.67	2.49	0.00	0.36	0.89	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.50	89.88	1.31	2.18	2.61	0.44	0.65	1.09	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.09	44.95	0.70	2.58	1.64	1.17	0.94	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	31.15	65.48	1.06	1.58	2.11	1.06	0.00	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	58.80	0.00	1.11	5.55	1.11	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.79	61.73	0.45	5.21	1.78	1.34	1.04	0.59	0.59	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	20.35	62.46	1.40	3.19	4.59	1.20	1.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.44	65.17	1.46	2.91	3.54	1.04	0.62	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.17	72.30	1.83	6.18	4.35	0.46	1.37	2.06	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	23.30	62.66	0.90	2.71	3.85	1.13	0.68	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.46	52.81	1.75	4.36	2.62	0.87	3.06	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.82	82.58	1.08	6.19	4.03	1.08	0.81	1.08	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.53	69.09	1.05	4.88	3.84	1.40	1.22	0.35	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.40	85.01	0.84	5.89	3.37	1.68	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.62	74.95	0.55	4.23	2.39	0.55	0.73	1.29	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.91	85.25	0.70	4.93	1.76	0.70	0.70	0.70	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.11	75.90	0.00	3.07	3.95	0.44	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.81	66.44	1.92	3.14	2.44	0.70	1.39	1.57	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.65	68.76	0.00	4.83	2.60	0.00	1.49	1.86	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	36.00	97.43	1.08	3.66	3.45	1.51	0.65	0.65	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.47	69.20	1.23	2.87	6.55	1.64	0.41	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.91	61.19	0.46	3.01	5.10	0.46	0.23	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.33	73.54	0.70	3.25	3.48	0.46	0.70	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	68.22	1.53	1.31	1.53	2.18	0.65	1.09	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	29.34	74.15	1.39	2.31	0.69	1.62	0.69	0.92	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	32.28	87.08	0.87	2.17	0.87	1.30	1.08	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	47.81	90.01	1.56	3.11	1.56	1.09	1.40	1.56	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	38.77	73.70	0.70	2.45	0.70	1.22	0.87	1.40	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	34.78	78.71	0.67	2.90	1.34	0.89	0.67	0.67	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	38.02	92.88	0.51	2.30	1.28	2.04	0.51	0.77	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	38.42	70.26	0.88	1.54	2.42	2.20	0.88	1.54	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	38.74	96.64	0.63	2.11	2.11	1.89	0.84	1.68	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	221.52	73.16	12.19	10.16	6.10	4.06	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	198.65	92.21	18.98	12.20	5.42	8.81	2.71	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	195.73	67.31	18.64	4.14	5.18	8.28	2.07	3.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	230.81	85.82	16.52	9.06	4.26	6.40	1.07	3.73	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	213.35	104.53	13.94	10.72	8.04	4.29	3.22	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	226.02	87.74	11.93	10.53	1.40	6.32	7.02	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	237.66	89.42	11.77	13.33	5.49	7.84	2.35	1.57	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	237.29	75.14	23.73	9.23	1.32	3.95	3.95	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	175.06	103.56	5.75	11.51	4.11	3.29	4.11	2.47	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	118.24	97.93	3.63	5.80	8.71	2.18	5.80	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	133.78	119.14	7.07	9.09	6.56	2.02	2.52	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	150.71	64.25	4.44	4.85	4.85	1.62	0.81	3.64	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	127.04	57.13	2.40	2.40	3.60	1.20	0.00	2.80	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	43.17	72.29	3.01	6.02	8.03	3.01	7.03	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	59.55	84.27	1.69	3.37	15.17	2.81	2.81	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	89.81	73.65	1.88	3.76	2.25	5.64	3.76	0.75	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	75.09	75.76	4.51	5.41	4.06	6.76	2.93	1.13	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	154.96	152.46	4.64	8.93	11.43	1.79	5.00	2.86	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	125.53	183.10	3.06	14.70	20.82	1.84	5.51	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	124.74	170.49	3.66	9.45	11.28	1.22	3.35	0.91	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	110.26	75.81	3.57	6.64	6.38	6.38	2.81	1.28	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	130.04	84.67	3.59	4.49	4.04	6.29	2.02	2.70	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	120.16	87.68	4.02	8.05	3.16	4.31	1.72	1.44	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	177.78	128.48	5.22	14.22	6.16	4.27	2.84	2.37	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	201.57	145.38	1.40	16.86	4.21	4.92	2.11	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	158.22	174.70	0.00	9.89	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	90.90	67.92	3.32	7.23	5.20	5.78	2.02	1.01	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	104.56	73.72	3.39	12.54	10.34	3.73	3.56	1.69	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	101.08	76.09	3.87	10.16	11.28	4.84	3.06	1.29	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	148.39	121.49	3.59	12.10	6.28	4.03	2.24	2.69	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	173.30	135.21	4.54	11.18	10.48	9.08	4.19	1.75	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	124.07	110.00	4.84	8.80	6.60	6.16	3.96	1.76	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	91.50	67.46	3.79	5.90	4.22	7.59	2.95	2.11	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	82.48	82.07	3.74	9.56	4.99	6.23	3.12	1.25	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.19	83.87	3.01	6.68	3.34	5.35	2.00	1.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	170.23	137.33	1.63	13.05	4.62	9.52	3.54	1.90	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	175.26	150.60	1.61	8.04	3.75	7.50	5.36	2.14	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	145.25	181.12	0.00	12.55	0.00	7.17	1.79	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	109.77	87.15	4.64	7.60	4.64	8.16	2.41	1.67	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	102.46	81.23	2.17	8.23	5.63	4.12	1.52	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	90.79	80.91	1.89	9.67	4.83	6.51	2.31	3.15	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	128.93	131.46	4.04	10.11	7.08	4.04	7.08	2.02	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	140.37	142.11	0.87	13.00	4.77	5.20	5.63	1.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	91.96	130.31	1.74	6.54	3.92	4.79	2.61	2.18	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	189.04	142.52	1.48	9.90	3.46	6.93	4.95	3.96	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	173.56	108.94	1.85	9.23	7.39	9.23	3.69	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	195.42	117.25	1.40	8.37	4.19	4.19	4.19	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	210.19	115.76	3.32	4.15	5.26	7.20	4.98	1.66	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	183.80	121.47	1.72	5.40	4.42	7.61	4.91	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	135.52	104.72	4.62	4.62	0.00	10.78	1.54	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	133.94	122.48	2.86	9.31	1.07	6.45	2.51	2.51	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	189.74	117.72	1.38	5.54	4.15	9.69	8.31	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	118.84	103.13	5.89	13.10	8.84	4.26	3.60	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	102.49	107.37	4.51	9.01	16.14	0.38	1.50	0.38	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	163.61	138.11	2.02	16.16	12.88	2.78	4.54	1.51	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	97.49	40.83	23.63	3.21	6.19	0.23	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	92.26	34.03	14.14	2.16	4.07	0.72	0.96	1.68	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	90.29	30.92	15.32	1.92	3.56	1.09	1.09	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	60.04	32.72	19.81	2.70	3.60	1.20	0.30	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	80.63	34.80	18.00	2.64	3.36	0.72	0.24	0.48	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	104.37	36.84	22.97	4.32	3.18	2.27	0.00	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	104.30	34.55	23.03	1.96	3.48	2.39	0.43	0.87	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	92.12	36.06	22.37	2.63	2.90	2.37	0.53	0.53	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	108.35	31.66	24.86	3.52	3.99	3.28	1.17	0.94	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	109.88	33.21	25.66	4.83	3.02	1.81	1.51	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	104.58	37.48	24.98	4.07	4.07	2.03	0.58	0.87	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	101.51	39.43	22.65	4.53	2.13	2.13	0.00	1.33	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	93.24	41.15	20.57	4.82	10.51	0.00	0.00	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	100.19	39.62	22.32	3.19	11.84	0.00	0.00	2.28	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	83.54	53.70	20.88	5.22	17.90	0.00	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	99.76	46.10	15.49	4.32	3.24	0.72	2.16	1.08	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	96.96	45.75	18.99	3.74	5.47	0.86	1.73	1.15	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	94.04	46.20	26.87	4.71	4.95	1.41	1.89	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	108.70	31.69	21.87	3.80	3.17	0.95	1.58	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	111.95	38.14	18.76	4.00	2.77	1.85	0.31	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	107.40	39.75	24.36	3.21	3.53	1.28	0.32	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	98.68	41.69	18.74	4.21	2.68	0.38	0.76	2.29	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	84.73	35.08	16.16	6.31	4.73	1.97	0.00	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	93.04	28.74	23.45	3.03	3.78	1.51	0.76	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.92	53.80	16.86	4.82	5.62	1.61	0.00	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	104.21	68.54	16.09	3.50	14.69	1.40	0.00	2.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	111.19	78.14	18.03	3.01	13.02	1.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	32.90	20.11	1.83	3.66	5.48	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	52.37	28.16	2.47	0.99	1.48	3.46	0.99	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	83.98	37.99	4.31	0.95	1.05	1.47	0.53	0.32	0.63	0.00
Chondrocyte - de diff, donor1	11261-116G1	73.15	46.45	3.81	1.39	2.43	4.51	1.04	0.69	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	39.09	28.79	1.07	1.78	1.78	0.71	1.78	0.36	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	59.17	39.03	2.84	3.07	2.16	1.82	1.59	0.68	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	44.76	43.87	1.79	2.69	2.69	1.79	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	50.15	36.40	3.24	2.43	2.43	1.62	1.21	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	96.63	44.87	3.79	1.72	1.26	2.18	1.03	2.07	0.46	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	76.31	32.28	5.56	2.57	2.35	1.92	0.43	0.86	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	84.16	43.36	5.75	3.10	2.48	1.15	1.24	1.33	0.18	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	113.25	100.32	5.14	3.85	3.03	3.39	1.28	5.04	21.82	2.57
Corneal Epithelial Cells, donor1	11526-119I5	143.82	60.60	11.20	2.85	1.54	0.00	0.66	1.32	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	87.60	61.43	11.38	3.41	3.41	2.28	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	130.37	70.30	11.25	1.53	5.37	0.77	0.26	0.77	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.40	29.22	6.93	1.82	0.83	1.49	0.50	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	54.25	34.06	8.52	2.21	1.58	0.95	0.95	1.26	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	41.41	3.45	3.45	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.15	40.82	7.45	2.92	2.27	0.43	0.97	0.43	0.32	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	119.92	113.42	7.17	16.74	6.15	4.44	4.44	1.71	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	81.61	112.29	4.57	9.14	5.22	4.57	7.18	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	119.53	107.44	5.32	7.26	6.78	8.23	9.19	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	79.72	33.35	6.84	1.83	2.84	1.00	1.67	0.67	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	48.12	18.78	2.35	3.52	3.52	2.93	2.35	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	130.37	45.53	10.46	3.11	4.24	1.70	1.41	1.41	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	61.73	31.45	4.72	3.54	1.97	3.15	1.57	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	81.74	51.48	10.18	4.36	5.53	2.62	1.75	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	109.17	52.94	9.18	4.71	4.94	1.88	0.94	1.65	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	63.99	25.60	6.14	2.98	3.51	0.70	0.53	0.88	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	80.46	33.03	5.98	0.89	2.22	3.55	2.22	0.66	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	79.11	36.51	5.78	1.52	2.74	2.43	1.83	1.22	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	82.32	49.90	7.05	3.38	1.69	3.66	0.85	1.69	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	78.74	40.11	5.65	1.49	1.49	2.08	1.19	1.49	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	54.15	26.03	5.73	3.12	0.52	2.60	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	63.80	52.74	4.82	3.97	2.27	2.13	2.41	1.28	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	137.64	57.62	10.00	2.00	5.60	1.20	0.80	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	61.85	57.65	5.24	2.62	5.77	2.10	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	137.79	55.41	11.18	3.11	3.60	5.72	2.61	1.74	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	114.71	80.82	8.47	5.87	3.26	2.61	2.17	0.22	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	161.70	86.34	13.92	4.89	5.25	3.05	1.59	1.59	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	56.88	36.40	3.41	4.55	4.55	1.14	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	52.39	32.13	5.59	1.40	4.89	1.40	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	89.49	47.89	7.69	6.12	4.40	2.04	2.83	0.94	0.16	0.00
Eosinophils, donor1	12244-129H3	106.73	121.98	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	85.81	255.79	0.00	8.25	0.00	0.00	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	192.61	3.57	3.57	0.00	0.00	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	124.85	37.63	8.06	1.22	1.22	0.73	0.49	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	135.21	68.65	6.24	0.00	6.24	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	57.06	54.60	4.52	2.05	2.87	4.52	0.82	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.87	23.43	6.35	2.96	3.83	1.86	0.77	0.55	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	87.10	47.99	6.50	4.44	2.93	3.90	1.73	0.22	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	76.16	32.26	6.19	1.70	2.18	1.46	0.73	1.21	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	37.12	10.51	3.28	1.36	2.05	1.64	0.55	0.68	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	61.28	38.50	3.59	2.74	2.74	2.00	1.27	0.74	0.42	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	44.00	16.07	1.58	1.05	0.53	0.53	0.79	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	93.35	47.50	3.99	2.99	4.98	1.66	1.33	1.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	61.69	40.83	4.08	3.18	0.91	1.81	2.27	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	42.45	35.62	3.79	1.52	0.76	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	55.52	32.80	4.42	2.84	2.84	0.32	1.73	0.47	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	76.08	41.53	5.76	2.42	0.91	1.52	0.91	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	81.60	38.45	3.30	3.17	1.78	1.52	2.54	0.13	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	82.01	40.02	4.09	2.43	2.12	4.24	1.52	0.61	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	103.57	50.92	3.48	1.47	2.28	3.89	1.61	0.00	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	47.89	31.06	1.29	0.86	2.16	5.18	1.29	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	111.32	39.55	0.00	1.46	0.00	0.00	2.93	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	226.95	119.93	10.38	5.54	2.54	0.46	2.54	2.31	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	71.74	38.67	2.04	1.87	0.68	5.60	3.90	1.53	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	74.43	30.99	3.29	1.17	1.64	1.41	1.17	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	60.85	26.41	3.30	1.42	1.89	0.94	0.47	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	89.58	35.90	4.71	1.33	0.85	2.66	1.45	0.36	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	119.04	39.91	3.96	1.47	1.92	1.70	1.24	0.45	0.45	0.00
Fibroblast - Dermal, donor5	11454-119A5	137.99	41.52	4.54	1.40	1.92	2.44	1.40	1.22	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	143.09	42.07	5.36	3.09	3.41	3.74	1.46	0.65	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	80.38	32.69	2.29	2.08	0.83	2.08	1.04	0.83	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	27.25	1.83	1.05	1.83	1.83	1.31	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	117.29	41.91	4.09	2.24	1.32	2.90	1.84	1.19	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	102.78	58.69	1.55	3.38	1.84	2.03	2.22	0.87	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	68.57	44.67	6.23	2.08	2.08	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	61.50	37.36	0.70	2.29	2.11	1.59	0.53	1.23	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	76.39	36.01	4.99	2.03	2.03	1.40	1.40	0.62	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	75.32	22.18	4.06	2.03	1.22	2.03	1.89	0.27	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	107.63	55.75	9.88	3.88	4.23	0.35	0.35	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	58.50	27.20	2.49	1.61	1.90	2.78	1.61	0.44	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	50.18	21.54	3.14	1.64	1.36	2.45	0.68	0.82	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	89.29	27.97	9.76	1.76	2.74	1.65	0.99	0.77	0.44	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	54.44	38.74	2.49	2.49	0.59	3.08	2.79	0.73	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	39.42	17.67	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	77.59	47.75	1.49	2.98	1.49	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	106.78	47.91	4.22	3.17	1.06	2.11	1.48	0.84	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	210.75	84.97	6.66	0.83	5.00	1.67	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	90.91	43.36	5.59	1.40	2.80	0.00	2.80	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	54.30	39.46	3.64	1.96	1.12	1.12	1.12	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	176.60	64.14	13.80	4.47	5.68	1.22	1.22	1.22	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	131.81	71.90	0.00	3.99	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	41.69	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	106.49	32.01	3.10	2.52	0.58	1.94	0.19	1.94	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	153.05	56.73	6.67	2.28	2.12	0.76	1.37	1.67	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	123.01	43.14	9.49	1.22	1.22	0.92	0.61	1.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	54.19	36.25	1.53	2.67	0.76	1.14	0.76	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	51.84	34.02	1.89	4.59	3.24	1.62	1.08	1.62	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.89	35.02	1.62	3.60	1.39	1.16	0.93	0.70	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	80.47	32.94	9.28	3.54	3.21	2.76	0.99	0.55	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	154.63	61.77	8.13	1.63	2.24	0.41	0.41	1.63	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	104.24	46.77	4.01	4.01	1.34	0.67	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	68.00	52.58	1.58	3.56	1.19	3.56	0.79	1.58	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.46	16.87	2.78	0.79	2.18	1.79	0.20	0.60	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	47.07	37.30	2.13	1.95	0.53	2.49	0.53	1.24	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	58.34	28.97	3.35	0.99	1.18	1.58	0.39	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	42.42	14.44	3.31	0.60	2.41	1.20	0.60	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	77.19	30.98	4.32	1.08	1.51	2.27	1.30	0.32	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	40.49	18.73	2.02	0.25	1.27	1.52	0.51	0.25	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	60.05	39.54	3.77	1.97	1.15	1.64	1.15	0.66	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.29	13.63	2.41	0.60	1.60	0.40	0.40	0.60	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	71.83	37.17	3.21	2.31	1.61	2.21	0.50	0.50	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.47	17.23	2.42	1.21	0.91	2.72	0.30	1.51	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	61.39	37.78	2.73	2.49	1.24	2.07	0.91	0.50	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	83.77	34.02	1.88	0.68	1.54	2.22	1.71	0.17	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.07	18.06	1.31	1.64	1.31	0.99	0.00	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	81.06	38.03	3.52	1.38	3.30	2.24	0.96	0.43	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	64.44	43.35	4.39	3.20	3.20	1.52	0.51	1.35	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	37.17	30.42	2.82	2.67	0.78	3.29	0.94	0.78	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	42.71	55.78	1.74	3.49	3.49	1.74	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	65.53	31.20	10.23	3.29	1.73	1.04	0.52	0.87	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	75.73	31.49	13.01	3.64	2.86	0.78	1.30	1.04	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	62.86	30.92	12.52	3.58	3.83	0.51	1.53	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	135.50	61.24	18.37	6.89	8.42	2.30	1.53	3.06	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	153.78	47.22	25.52	5.10	5.10	1.91	1.28	3.19	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	213.38	93.57	24.25	5.13	3.14	8.56	3.42	0.86	2.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	198.82	137.33	7.45	4.14	1.93	4.14	2.76	2.76	1.93	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	102.52	119.41	5.02	5.94	2.51	4.11	2.28	3.20	1.60	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	210.61	120.07	14.86	6.74	6.34	3.96	5.94	1.19	1.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	161.77	116.84	6.08	2.38	1.32	6.61	5.29	1.85	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	81.86	153.29	3.26	7.18	3.59	2.61	3.26	2.28	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	181.31	72.08	17.25	5.31	6.19	3.10	3.10	3.54	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	244.63	51.72	10.60	2.54	2.26	3.11	2.83	5.65	2.40	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	204.29	61.57	9.24	2.09	2.09	1.72	2.46	3.32	1.60	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	176.22	57.49	20.95	2.95	3.22	2.42	1.07	4.57	1.88	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	218.42	62.94	10.90	2.85	2.48	1.24	1.86	2.85	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	216.50	49.00	10.24	1.80	2.63	1.11	0.97	2.21	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	150.04	46.15	12.20	2.03	2.24	3.25	1.63	1.42	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	151.28	60.92	5.48	2.74	2.97	1.83	2.28	2.05	1.14	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	183.24	48.71	7.60	1.87	2.37	2.24	1.62	1.87	1.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	195.84	45.03	7.87	1.53	2.19	1.97	2.62	1.75	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	146.85	87.17	6.21	4.14	2.95	2.66	1.18	2.07	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	166.91	68.35	9.38	5.40	2.70	1.43	1.11	3.02	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	158.40	65.91	8.94	4.47	2.90	1.34	0.67	2.23	1.56	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	124.41	80.86	3.63	5.44	2.82	3.63	1.01	1.21	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	129.44	70.23	6.28	3.73	2.88	3.05	1.53	1.87	1.70	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	147.20	61.80	13.21	3.37	4.79	3.10	1.15	2.57	0.89	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	154.42	84.60	6.87	3.02	1.14	2.50	1.04	5.20	0.83	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	136.11	87.78	4.44	1.71	1.37	3.24	2.56	2.39	1.20	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	134.55	71.59	4.65	3.54	2.88	2.55	1.88	3.54	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	121.72	60.57	8.49	3.49	3.58	2.16	1.50	2.83	1.08	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	113.52	64.32	6.74	3.27	3.27	2.86	0.41	2.86	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	107.07	74.06	3.92	3.30	1.86	2.48	3.09	1.44	1.03	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	130.28	64.56	4.38	2.65	3.00	2.65	2.54	2.54	0.92	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	99.89	79.71	3.67	4.50	4.34	3.00	2.17	1.83	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	99.63	87.07	4.19	2.87	2.42	1.54	0.88	1.98	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	131.97	70.23	5.04	2.58	2.71	3.20	1.84	1.35	0.61	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	100.17	74.72	6.97	5.19	3.08	1.78	1.46	1.62	0.49	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	111.29	66.71	2.25	2.57	1.60	1.92	1.28	2.25	0.64	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	112.00	61.97	3.32	3.32	3.13	1.80	1.61	2.46	0.57	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	104.55	82.88	3.64	4.90	3.80	2.06	3.01	1.58	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	91.23	80.58	5.47	3.04	3.34	2.74	0.61	1.52	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	109.97	68.58	4.29	3.97	2.20	1.99	1.05	1.78	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	90.68	70.70	2.85	4.61	3.07	1.76	1.54	1.54	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	88.65	70.42	5.61	5.05	2.52	0.84	1.68	1.96	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	67.59	51.39	5.00	4.44	4.72	2.31	1.20	1.30	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	71.40	68.99	5.35	4.81	6.15	3.21	1.87	0.80	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	88.13	83.39	5.05	8.26	9.33	2.45	1.07	0.92	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	90.29	65.68	8.03	4.40	5.18	3.63	2.07	1.17	0.52	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	77.80	84.30	2.98	7.86	4.34	2.44	1.08	1.08	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	83.33	61.57	3.69	5.71	2.21	2.58	0.92	1.66	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	82.02	60.31	2.41	3.07	4.17	2.41	1.32	0.66	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	135.87	154.71	5.95	5.95	4.96	0.99	2.98	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	79.94	64.37	5.54	4.88	3.69	2.77	1.19	1.32	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	69.81	45.80	2.82	6.05	2.02	2.22	2.22	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	200.28	103.95	6.86	4.57	2.03	1.27	1.78	3.56	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	257.78	58.32	15.92	1.79	3.38	4.18	1.39	3.18	1.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	255.30	46.99	11.09	2.00	0.77	4.78	1.54	3.70	2.16	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	278.03	63.83	19.44	3.27	2.05	3.27	1.84	5.73	2.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	160.85	74.16	23.78	5.01	4.38	4.38	1.25	1.56	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	168.97	61.60	20.91	4.80	5.09	3.96	1.13	3.67	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	168.34	63.65	12.45	4.15	3.69	2.77	0.00	3.69	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	150.96	81.67	19.80	2.47	7.42	2.47	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	143.12	66.53	18.57	3.87	6.96	4.64	0.39	3.48	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	194.14	123.54	16.04	8.02	8.02	0.00	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	121.72	66.08	6.96	3.48	3.48	6.96	0.00	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	116.52	75.51	10.42	3.91	5.21	5.53	1.30	2.93	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	134.25	59.71	11.12	2.06	4.12	2.47	1.65	2.88	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	133.29	109.96	13.33	3.33	13.33	6.66	0.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	94.24	64.60	5.87	5.59	3.36	4.47	1.96	1.68	1.40	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	104.26	67.66	10.13	4.58	3.92	4.25	0.00	2.94	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	114.08	83.88	5.87	2.52	0.00	1.68	0.00	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	97.01	64.25	6.36	2.86	1.91	3.82	0.95	2.23	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	106.65	60.12	4.42	1.70	2.04	3.74	1.36	2.04	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	110.67	58.47	2.09	2.09	0.00	4.18	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	135.16	70.44	3.44	1.72	1.15	1.15	1.15	2.86	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	96.79	70.74	4.74	1.48	3.26	3.26	1.18	2.07	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	74.54	96.57	3.39	3.39	5.08	3.39	0.00	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	98.58	79.94	5.38	5.38	6.21	3.73	0.41	4.56	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	81.70	79.16	5.98	3.91	3.22	3.22	0.69	2.30	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	89.56	0.00	10.54	0.00	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	79.96	63.81	3.08	3.46	3.46	3.08	2.31	1.92	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	85.73	66.82	4.24	2.28	2.28	1.96	0.98	2.61	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	115.71	100.99	4.01	2.01	3.34	10.03	5.35	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	136.77	74.36	2.31	1.54	1.93	6.93	1.54	1.93	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	122.90	109.89	8.90	6.16	7.87	6.16	1.71	2.05	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	96.91	67.09	0.00	2.48	2.48	2.48	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	128.34	85.88	0.47	1.42	2.83	4.72	2.36	0.00	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	133.37	67.59	4.83	1.81	1.21	2.41	1.21	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	111.91	104.28	3.05	1.53	2.03	4.58	1.53	2.54	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	97.32	82.96	2.39	1.99	3.19	3.99	1.60	2.39	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	133.70	85.35	4.93	1.48	1.97	4.44	0.99	1.48	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	105.06	59.02	3.54	3.54	0.00	1.18	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	109.69	75.85	1.17	1.17	2.33	3.50	0.00	2.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	162.83	60.13	3.51	1.32	2.63	1.76	1.32	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	108.50	72.05	5.93	0.85	2.54	0.85	1.70	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	72.23	59.09	3.58	3.58	5.37	4.18	0.00	1.79	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	67.45	65.02	2.91	0.97	4.37	3.40	1.94	2.91	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	34.24	19.40	1.14	0.00	1.14	2.28	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	49.07	32.85	3.33	2.49	4.99	0.00	0.83	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	49.48	30.36	2.25	1.12	4.50	3.37	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	43.13	31.40	1.90	0.32	2.22	1.59	0.32	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	39.27	17.96	0.42	0.84	1.25	2.09	1.25	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	74.96	26.92	8.94	2.20	3.71	2.20	2.09	1.74	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	72.58	27.68	8.44	2.36	3.88	1.52	0.51	0.34	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	71.66	26.85	7.28	2.05	3.41	1.82	0.68	0.68	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	81.44	24.59	11.15	3.17	3.17	2.30	1.31	1.20	0.66	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	71.35	29.66	8.81	3.22	3.22	1.29	0.86	0.64	0.86	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.22	22.82	9.26	1.08	1.51	2.15	0.00	0.86	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	66.75	27.40	9.34	2.24	3.36	1.87	1.25	0.87	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	61.07	23.67	6.35	2.74	3.26	1.72	0.51	0.51	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	56.07	17.30	7.05	1.60	2.24	2.56	0.96	1.28	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	124.24	92.34	5.04	2.24	9.51	3.92	8.39	1.12	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	100.84	60.16	4.76	3.90	2.60	3.03	2.60	2.16	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	63.45	7.93	5.29	5.29	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	76.89	49.73	7.05	1.76	3.17	2.47	1.76	1.06	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	64.66	52.31	2.18	1.45	1.45	1.45	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	71.68	34.09	4.02	3.32	3.50	2.10	1.22	0.70	0.17	0.00
Hepatocyte, donor1	11523-119I2	36.32	32.69	4.84	0.00	0.00	4.84	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	44.17	57.10	11.85	4.31	1.08	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	58.29	34.97	2.45	1.84	2.45	0.61	0.61	0.61	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	86.15	50.26	1.96	5.87	9.14	5.87	0.65	1.96	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	133.36	49.81	11.71	2.97	2.97	4.89	1.57	1.40	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	85.62	27.44	7.68	1.51	1.92	1.78	1.78	0.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	162.38	38.21	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	40.05	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	88.60	55.38	5.54	1.38	1.38	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	112.62	27.53	0.00	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	94.83	38.44	5.13	2.56	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	27.42	0.00	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	118.58	35.74	14.62	3.25	3.25	0.00	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	111.71	26.68	6.67	3.33	3.33	1.67	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	98.03	29.04	3.63	3.63	0.00	0.00	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	116.47	45.00	9.26	1.32	3.97	1.32	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	110.86	44.35	3.33	2.22	3.33	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	31.43	20.95	5.24	0.00	0.00	0.00	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	113.38	40.31	8.19	1.26	1.26	1.26	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	125.28	40.21	6.19	1.55	0.00	3.09	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	120.81	29.72	9.69	0.00	1.94	3.23	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	109.47	37.03	4.83	4.83	3.22	0.00	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	123.05	36.67	10.59	1.63	0.81	1.63	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	107.47	26.87	10.92	2.52	0.84	0.84	0.00	2.94	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	131.00	33.75	9.64	2.41	3.21	0.80	1.61	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	117.26	49.86	11.08	3.69	0.92	3.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	45.24	0.00	15.08	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	120.84	33.04	7.55	2.83	3.78	1.42	1.89	0.94	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	84.35	46.26	8.16	0.91	0.91	1.81	3.63	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	88.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	134.51	41.97	6.46	3.23	1.08	1.08	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	116.88	53.36	16.52	0.00	1.27	2.54	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	49.29	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	114.78	45.91	7.65	0.64	3.19	0.00	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	94.78	32.81	9.11	3.65	3.65	1.82	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	63.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	100.68	34.28	10.00	2.14	2.86	1.43	0.00	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	76.32	43.14	13.27	3.32	6.64	3.32	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	123.77	39.51	11.73	0.93	2.78	0.93	0.00	1.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	121.17	47.41	12.29	0.00	1.76	1.76	5.27	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	84.86	47.15	0.00	3.14	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	118.22	43.81	11.82	0.70	2.78	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	88.52	75.25	8.85	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	139.41	32.42	6.48	0.00	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	112.48	39.24	6.98	0.87	0.87	0.00	0.00	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	130.49	51.75	2.25	11.25	6.75	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	114.99	55.75	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	123.75	46.94	6.40	2.13	2.13	1.07	1.07	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	105.29	49.88	9.70	5.54	5.54	0.00	0.00	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	42.74	8.55	0.00	0.00	2.85	0.00	5.70	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	124.26	33.14	9.20	1.84	0.92	1.84	0.00	3.68	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	108.91	48.41	9.08	6.05	0.00	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	74.50	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	120.54	44.41	2.11	2.11	1.06	1.06	3.17	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	90.09	26.60	12.89	0.98	1.88	0.73	0.33	0.49	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	49.78	25.18	5.27	1.76	1.76	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	128.83	46.57	7.95	2.65	1.70	1.33	0.85	0.57	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	150.30	55.74	8.17	1.48	1.14	1.70	0.45	0.79	0.45	0.00
Keratocytes, donor1	11527-119I6	202.52	130.66	6.19	3.44	2.06	0.34	0.34	3.09	0.69	0.00
Keratocytes, donor2	11607-120I5	96.09	42.18	0.00	4.69	0.00	0.00	2.34	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	86.94	63.63	0.40	1.38	0.99	1.38	0.59	0.99	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	129.68	4.40	4.40	2.20	0.00	2.20	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	80.91	30.20	1.08	1.08	2.16	0.00	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	106.91	47.52	4.04	1.96	1.96	1.73	1.38	1.27	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	77.09	31.48	5.25	1.41	3.13	2.02	1.11	0.91	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	60.12	41.50	4.15	2.02	1.54	1.66	1.30	0.83	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	58.61	31.54	4.74	2.51	1.67	1.95	0.28	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	53.36	34.95	4.56	2.20	2.68	3.46	1.26	0.79	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	46.24	34.95	4.30	3.76	0.54	1.61	2.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	60.51	29.63	4.10	1.58	1.26	0.63	1.26	1.26	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	48.84	31.70	4.10	1.94	1.62	1.83	1.29	0.86	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.12	33.65	3.28	3.28	2.46	1.23	2.05	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	56.88	36.15	5.06	2.53	2.28	1.26	0.76	1.26	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	52.92	34.48	3.80	2.25	3.10	2.25	1.13	0.42	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	46.28	33.22	1.19	1.98	1.19	1.58	0.00	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	61.85	36.06	4.27	2.91	1.16	1.55	1.74	0.58	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	49.06	28.33	3.33	0.56	1.30	1.30	1.30	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	50.87	42.86	4.88	3.14	0.35	2.09	1.39	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	63.92	38.64	7.39	1.91	2.86	1.43	1.43	0.72	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	46.84	32.96	3.85	1.92	1.65	2.06	1.51	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	53.89	40.65	3.39	1.54	2.46	1.54	1.54	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	52.68	30.86	3.12	2.49	2.18	1.87	1.56	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	55.81	31.84	4.39	2.20	1.83	2.38	1.10	1.10	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	54.63	40.48	3.29	2.63	1.32	1.97	2.30	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	53.01	28.41	4.39	2.34	1.76	0.88	2.34	0.88	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.31	32.11	4.23	1.49	1.49	1.49	1.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	48.01	29.58	6.79	2.91	0.97	0.97	1.45	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	63.82	43.36	6.19	1.89	2.96	1.08	0.81	0.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	53.44	34.06	5.30	1.67	2.27	1.97	1.82	0.45	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	46.66	28.51	3.63	2.07	2.07	1.56	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	65.54	33.50	3.56	1.68	3.14	1.47	1.26	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.63	37.44	2.86	1.50	2.26	1.50	3.01	0.90	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	52.97	37.15	4.82	0.69	0.00	0.00	2.75	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	66.42	34.05	3.95	1.69	1.32	2.26	1.88	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	50.79	35.10	3.39	1.48	1.91	2.01	1.48	0.85	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	59.12	27.62	3.88	1.45	2.42	2.42	0.97	2.42	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	66.82	40.03	5.95	1.98	3.31	1.32	0.33	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	51.54	31.22	4.34	1.86	1.73	2.23	0.99	0.99	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	52.57	35.54	4.44	1.48	2.59	3.33	2.22	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	57.57	34.84	3.21	1.73	1.73	0.74	0.99	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	50.19	32.17	4.12	3.02	1.51	1.37	1.10	0.96	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	53.71	36.99	2.89	1.93	1.29	1.93	1.29	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	68.47	41.08	7.61	2.13	2.74	3.04	0.61	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	53.05	34.15	3.50	1.96	2.66	2.66	1.82	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	49.42	24.18	2.13	1.78	3.56	1.78	2.13	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	65.44	42.66	5.33	3.39	1.45	0.00	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	51.97	30.19	3.27	1.71	2.65	1.71	0.93	0.47	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	55.15	37.60	3.58	2.15	3.58	1.79	1.07	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	74.16	43.77	6.21	2.29	3.27	0.98	0.98	1.96	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	43.32	22.37	4.94	1.18	0.71	0.94	1.18	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	69.67	40.47	5.20	2.48	1.73	2.35	1.36	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	66.08	33.55	5.89	2.31	2.05	0.77	0.51	1.02	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	51.62	38.49	4.77	2.69	2.09	2.09	1.49	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	49.85	9.06	9.06	6.80	0.00	0.00	6.80	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	82.08	56.00	3.84	2.30	9.21	0.77	1.53	0.77	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	77.93	42.31	5.94	1.48	3.71	0.74	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	77.01	43.16	8.46	4.23	5.92	2.54	0.85	1.27	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.89	47.83	11.96	4.92	7.03	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	73.78	60.71	3.74	4.67	4.67	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	48.44	30.40	7.73	2.06	4.64	2.58	0.00	2.58	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	60.66	55.90	9.52	4.76	9.52	0.00	1.19	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	65.14	40.94	6.79	3.17	6.56	1.58	0.68	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	61.07	41.88	7.85	1.16	6.11	1.45	0.29	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	67.98	55.37	8.10	2.25	3.60	2.25	1.35	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	79.12	45.25	13.41	2.17	4.61	1.76	0.95	2.44	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	62.65	49.30	4.62	2.05	6.16	1.54	1.54	0.51	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	64.22	55.75	7.41	1.06	7.76	2.47	1.06	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	60.63	45.31	2.67	1.33	6.00	0.67	0.67	0.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	67.75	48.90	6.11	3.06	6.62	4.08	0.00	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	77.11	54.43	8.27	2.13	5.87	1.33	0.80	2.67	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	65.00	46.29	7.18	2.65	7.37	1.32	0.38	2.46	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	61.36	54.61	12.27	2.45	8.59	1.23	0.00	2.45	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	106.82	61.16	5.71	1.63	12.23	2.45	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	70.18	48.73	8.33	3.54	5.83	1.25	1.04	1.87	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	61.66	36.43	5.89	3.64	7.01	3.36	0.56	2.24	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	80.37	56.67	3.09	3.09	7.21	0.00	1.03	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	73.74	48.48	8.13	2.90	10.16	2.32	1.45	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	59.79	40.06	10.16	2.39	7.77	1.49	0.00	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	68.05	52.01	9.41	3.87	6.64	1.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	83.07	48.78	13.79	4.24	9.54	1.77	0.71	2.47	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	73.02	50.15	9.96	1.48	6.64	2.21	1.11	0.74	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	84.04	59.87	5.76	4.61	4.61	1.15	1.15	2.30	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	82.12	54.88	10.75	2.69	8.83	1.92	0.00	3.07	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	62.84	40.76	9.06	2.26	6.23	2.26	0.00	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.84	45.95	4.10	1.64	9.03	0.82	0.82	0.00	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	81.34	44.74	8.13	3.16	7.23	1.36	0.45	0.45	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	65.35	44.52	7.90	1.44	7.90	1.44	0.00	1.44	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	67.97	49.30	12.70	0.75	11.20	1.49	2.99	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	79.15	40.50	10.40	3.72	4.09	2.23	0.74	1.86	1.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	60.74	40.49	7.32	4.31	3.02	1.72	0.00	1.29	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	70.22	55.66	11.99	4.28	8.56	3.43	0.00	1.71	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	74.63	49.98	8.66	2.67	10.33	2.67	1.33	0.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	76.02	34.99	4.83	4.22	7.84	4.83	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.86	60.43	5.69	2.84	7.11	0.71	1.42	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	79.74	45.03	12.37	2.06	7.56	3.44	0.69	1.37	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	55.82	31.67	5.90	1.61	6.44	4.29	0.54	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	73.40	49.83	9.43	3.37	6.73	3.37	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	80.38	47.41	5.56	3.33	6.30	1.11	1.85	1.85	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	39.54	5.81	2.33	9.30	4.65	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	56.06	46.54	8.46	4.23	4.23	1.06	0.00	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	74.43	48.82	8.40	1.20	6.40	1.20	1.20	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	67.60	52.33	5.09	5.81	8.00	0.00	1.45	2.91	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	90.45	59.79	10.73	5.37	7.67	3.07	1.53	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	73.01	53.27	7.40	3.45	3.95	1.97	2.96	2.47	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	63.98	39.52	4.70	1.88	1.88	2.82	0.00	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	75.42	63.36	11.56	5.53	7.04	2.01	1.01	2.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	73.45	52.72	13.07	4.96	5.86	2.25	0.90	0.45	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	53.35	36.14	5.16	3.44	3.44	1.72	1.72	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	92.19	56.11	8.02	3.12	7.13	0.89	0.45	2.67	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	83.29	60.61	5.87	2.74	9.38	1.17	0.39	2.74	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.16	44.86	5.94	2.64	5.94	0.66	0.00	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	81.47	52.93	4.67	4.67	7.78	0.52	0.52	2.08	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	76.14	51.20	10.06	2.19	6.13	2.63	0.00	1.75	1.75	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	71.56	45.85	5.03	3.91	6.15	2.24	1.12	1.12	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	76.40	62.71	11.04	3.53	6.18	1.32	0.44	0.88	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	79.84	48.60	8.87	3.47	4.63	2.70	0.77	3.47	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	76.46	40.51	11.14	2.53	8.10	1.52	0.00	1.52	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	84.11	57.19	8.17	3.36	7.21	1.92	0.00	1.44	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	65.20	56.05	11.13	1.99	3.98	1.59	1.19	3.98	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	69.27	49.22	10.94	3.04	9.11	3.04	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	80.93	36.66	10.38	0.00	4.15	0.00	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	75.24	55.10	6.08	5.32	7.22	1.14	0.38	1.90	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	72.30	47.51	10.84	4.65	7.23	0.52	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	94.33	45.95	10.28	0.00	4.23	1.81	0.60	2.42	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	67.82	47.85	9.51	1.27	6.97	0.32	1.27	1.27	1.58	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	84.23	57.04	11.19	3.20	9.60	2.67	2.13	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	113.21	34.48	9.19	0.00	5.17	4.60	1.15	1.72	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	98.73	56.57	14.91	5.14	6.17	2.06	2.06	2.06	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	77.81	62.25	9.90	0.00	9.90	0.00	2.12	2.12	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	123.71	51.64	10.78	2.84	7.38	3.97	1.70	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	82.79	56.58	12.48	2.50	7.90	2.91	0.83	2.08	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	89.27	51.68	9.40	2.35	7.05	3.13	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	118.58	43.01	12.53	0.84	6.26	3.76	0.42	2.51	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	87.82	62.73	14.40	3.25	8.83	0.46	0.46	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	97.68	60.21	9.37	4.68	12.71	2.01	0.00	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	120.29	54.53	11.23	2.67	11.23	2.67	2.14	2.14	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	101.83	57.38	15.36	2.42	11.31	0.81	0.81	2.83	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	80.76	69.75	13.77	5.51	11.01	0.92	0.00	0.92	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	166.26	69.35	10.67	0.89	11.56	1.78	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	113.97	59.27	11.40	1.71	9.69	1.14	0.57	1.14	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	108.13	55.98	12.27	3.07	12.27	3.07	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	124.76	48.15	11.49	1.09	7.11	1.64	1.09	1.64	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	98.44	61.03	11.14	5.35	10.69	0.45	0.00	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	86.31	44.45	15.08	2.86	10.66	0.78	0.78	2.60	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	125.99	51.72	12.60	1.33	11.94	4.64	1.33	1.99	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	137.19	72.75	12.47	4.16	8.31	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	48.55	42.39	1.60	2.05	0.91	0.46	0.68	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	62.21	26.06	14.86	1.47	3.12	0.92	0.00	0.37	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	75.24	51.78	12.98	2.75	3.41	1.44	0.26	0.66	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	66.91	38.23	14.34	2.66	3.72	1.06	1.06	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	70.04	35.65	9.19	2.54	3.01	2.69	0.95	0.95	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	82.56	36.69	17.79	3.61	3.06	2.36	0.83	1.11	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	118.77	71.44	11.46	4.48	4.19	1.79	1.10	1.30	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	103.66	52.41	7.24	3.76	3.76	3.19	0.58	0.87	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	58.62	21.95	3.74	2.00	1.50	1.75	1.25	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	87.45	86.78	9.49	2.71	7.46	2.03	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	85.32	96.57	4.87	6.81	7.25	4.00	2.27	1.19	0.11	0.00
Mast cell, donor2	11565-120D8	128.97	128.38	5.65	2.97	2.97	3.27	1.78	1.49	0.30	0.00
Mast cell, donor3	11566-120D9	160.06	152.18	3.83	3.15	2.25	4.28	2.48	1.80	0.00	0.00
Mast cell, donor4	11567-120E1	153.18	118.43	4.61	2.66	3.55	3.55	2.13	1.24	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	100.91	76.96	7.21	2.88	4.99	4.55	2.00	1.22	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	95.72	62.45	12.84	5.84	5.25	1.17	1.17	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	61.03	69.64	1.26	3.44	2.64	3.21	1.26	0.80	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	132.05	86.19	10.71	8.20	12.39	5.36	2.01	1.51	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	80.79	47.16	5.37	2.49	1.29	3.68	3.08	0.90	0.50	0.00
Melanocyte - dark, donor2	11582-120F7	44.64	30.80	2.77	1.04	0.69	3.46	1.38	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	97.58	58.10	4.71	4.06	2.54	2.39	0.43	0.72	0.22	0.00
Melanocyte - light, donor1	11274-116H5	66.29	52.66	4.94	4.94	2.59	0.24	0.71	0.94	0.00	0.00
Melanocyte - light, donor2	11351-117H1	40.27	30.03	1.36	3.41	4.09	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	31.22	20.81	0.87	3.47	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	97.25	43.73	4.37	2.08	1.35	1.98	0.62	0.94	0.73	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	67.77	33.08	6.99	4.84	1.34	1.08	0.81	1.08	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	67.23	57.32	4.02	1.87	0.27	2.14	1.87	1.87	0.00	0.00
Meningeal Cells, donor1	11493-119E8	186.34	79.40	8.56	1.49	3.72	1.74	0.87	1.24	0.50	0.00
Meningeal Cells, donor2	11573-120E7	131.60	76.59	5.28	3.08	5.72	1.32	5.28	0.44	1.32	0.00
Meningeal Cells, donor3	11654-122E7	97.31	46.78	8.23	3.02	2.93	2.36	0.82	1.55	0.49	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	97.81	33.65	5.42	3.71	1.43	5.42	1.43	0.86	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.56	19.22	3.22	1.51	2.72	1.61	0.81	0.30	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	53.88	46.00	1.31	1.31	0.00	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	62.79	19.62	5.23	1.31	1.31	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.81	35.88	9.33	2.87	2.15	2.15	0.00	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	51.04	37.69	4.24	1.27	2.12	2.12	1.27	0.42	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	36.69	28.65	4.02	2.51	0.50	2.01	1.01	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	112.51	56.70	5.49	3.96	4.61	1.76	1.32	1.10	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	107.40	54.06	13.15	1.46	2.92	3.65	0.73	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	100.05	50.95	5.52	4.50	3.68	1.23	0.82	1.84	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	72.99	37.95	1.11	1.25	1.52	4.57	3.32	0.55	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	53.90	42.38	2.60	1.49	0.74	0.74	0.74	0.74	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	72.10	42.10	2.76	0.53	1.32	2.89	1.71	0.66	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	48.67	28.19	3.26	0.59	1.48	1.48	1.78	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	30.36	2.34	2.34	0.00	2.34	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	95.42	46.11	7.04	0.64	3.20	3.20	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	88.61	32.96	5.67	2.48	0.35	1.42	1.06	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	60.67	42.22	2.81	1.88	0.94	1.88	1.56	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	87.81	49.35	3.63	2.18	2.18	2.90	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	47.47	25.46	3.71	0.80	3.18	1.06	0.27	0.53	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	45.04	26.02	5.00	3.50	3.50	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	51.74	28.62	5.93	2.75	2.82	0.43	1.66	0.58	0.79	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	39.16	8.10	1.35	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.05	24.63	6.40	1.23	1.72	1.48	0.49	0.25	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	47.70	22.08	7.66	1.18	2.06	0.00	0.29	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	10.37	6.91	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.23	24.80	4.03	1.55	1.86	1.55	0.93	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.12	16.59	8.30	0.41	1.04	0.83	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	18.53	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	46.80	30.53	5.76	1.00	1.25	2.00	1.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	69.36	29.79	9.78	1.40	0.93	0.93	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	46.94	28.04	5.08	1.42	0.81	1.83	0.81	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	35.24	14.65	5.94	1.19	0.40	1.19	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	9.73	1.77	1.77	0.00	3.54	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	48.25	17.10	6.46	0.00	0.76	1.14	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	14.47	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.87	17.19	2.97	1.49	1.06	1.49	0.85	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	39.60	23.94	6.45	0.00	1.84	0.00	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.64	25.04	4.77	1.79	0.60	1.19	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	18.44	8.38	5.03	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.37	19.07	4.52	0.75	1.76	0.50	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	47.06	22.58	10.93	0.24	1.90	0.95	0.48	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.95	9.40	0.55	0.55	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.24	19.34	5.07	0.92	1.61	1.15	0.46	0.46	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	32.60	13.04	6.52	1.47	1.05	0.63	0.63	1.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.85	24.46	4.69	2.45	0.82	1.43	0.82	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	32.82	19.09	2.57	0.86	0.43	0.86	1.07	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	59.13	19.78	10.45	0.89	2.00	0.67	0.22	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	20.64	0.00	0.00	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.51	27.16	6.13	1.31	0.44	0.22	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	57.29	23.83	7.10	0.00	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	23.20	0.00	0.00	4.97	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	36.69	29.35	4.89	1.09	1.63	1.36	1.36	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	52.93	21.76	15.88	0.88	1.47	0.59	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	27.26	1.09	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	33.64	29.31	5.29	1.92	1.44	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.42	18.81	11.21	0.40	0.40	0.40	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	35.65	47.99	2.74	2.74	2.74	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	41.05	24.03	6.51	2.00	0.00	0.50	1.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	40.77	2.04	6.12	0.00	0.00	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	42.48	30.65	4.82	1.75	0.44	2.19	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	41.94	15.45	6.62	2.21	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.10	35.86	7.04	2.56	3.84	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	43.88	32.97	8.43	1.49	2.23	0.99	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	30.62	11.83	0.70	0.70	2.78	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	33.15	8.84	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	54.02	22.91	4.79	1.37	1.71	2.05	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	32.38	10.07	7.00	0.44	3.06	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	53.62	31.96	8.17	0.71	2.84	0.00	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	55.55	23.29	8.42	0.84	0.56	0.28	0.56	0.28	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	11.64	5.40	1.66	0.42	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.13	27.39	5.24	2.91	2.91	0.58	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	49.77	24.43	7.84	1.51	2.41	1.21	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	39.65	18.37	4.59	0.42	2.50	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	36.09	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	45.25	22.17	4.62	1.85	2.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	43.25	17.64	6.26	0.57	1.14	0.57	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	41.73	20.45	5.67	2.35	1.38	0.55	0.69	0.55	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	47.94	21.51	7.00	2.33	2.33	2.85	1.30	0.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	69.07	33.03	12.44	2.57	2.14	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.95	27.31	5.72	5.08	1.91	0.64	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	43.77	24.29	7.21	1.07	1.33	1.60	0.53	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	44.60	27.54	7.78	0.90	4.19	1.20	0.30	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	43.93	23.87	3.96	1.27	1.70	0.14	0.85	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	51.60	18.79	11.15	1.59	2.87	0.64	0.64	1.59	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.39	23.00	11.28	1.11	1.55	0.00	0.44	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	37.16	28.82	4.93	1.52	1.14	1.14	0.76	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	52.84	25.29	5.68	1.99	2.56	0.57	0.57	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	50.39	19.91	11.06	0.74	3.20	0.98	0.49	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	39.75	21.51	3.91	3.91	3.26	0.00	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	56.16	28.81	7.64	2.06	2.35	0.88	1.18	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	61.41	23.35	9.23	2.31	3.46	0.58	0.86	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	63.47	31.32	9.48	2.89	0.41	0.00	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	50.33	33.05	5.06	2.98	3.57	0.30	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	39.21	1.78	1.78	1.78	3.56	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	51.59	41.40	3.29	3.29	0.00	0.99	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	38.92	42.08	2.10	1.05	0.00	1.05	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.68	24.71	1.58	0.40	0.40	0.59	0.99	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	51.22	49.36	2.79	0.93	0.93	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	35.68	40.18	0.38	1.50	1.50	1.13	2.25	0.38	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.63	30.63	2.40	1.33	0.80	1.33	1.33	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	33.59	27.71	1.02	0.79	0.34	1.13	0.23	0.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.21	36.84	2.21	1.47	2.21	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	32.61	33.34	1.10	1.47	0.37	0.73	0.73	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	31.11	1.56	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	42.76	58.25	2.67	0.53	1.07	1.07	1.07	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	46.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	63.63	3.03	3.03	1.01	2.02	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	43.01	1.69	2.95	1.26	2.95	1.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	62.65	0.00	2.72	1.36	4.09	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	45.14	68.03	4.45	2.54	2.54	2.54	1.91	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	38.06	76.93	1.62	2.43	1.62	4.05	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	69.48	3.02	6.04	1.51	3.02	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	68.52	5.71	5.71	28.55	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	71.77	91.35	26.10	6.52	39.15	0.00	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	66.53	14.26	9.50	9.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	25.10	12.55	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	71.31	36.19	2.37	1.72	3.66	1.51	0.22	1.08	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	64.80	62.71	1.05	2.61	1.57	3.14	2.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	54.07	52.73	6.01	3.34	5.34	1.33	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	65.53	58.85	5.84	3.76	5.01	0.42	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.35	65.03	5.13	7.23	5.70	0.95	1.14	0.57	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	98.94	143.63	3.19	6.38	6.38	1.60	3.19	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	27.20	2.72	4.76	0.68	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	58.80	42.27	3.68	5.51	7.35	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	30.55	0.42	3.77	0.84	0.84	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.73	42.30	4.42	3.49	4.42	0.46	0.23	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	39.72	43.78	1.62	2.97	3.24	0.81	0.00	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.54	31.96	1.26	1.89	2.52	0.63	0.84	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	33.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	47.15	36.23	1.49	2.98	3.97	1.49	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.76	22.47	1.08	1.89	1.08	0.81	1.35	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.03	28.34	1.59	3.17	2.27	0.45	1.36	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.92	41.32	1.31	3.43	2.94	0.82	0.49	0.16	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.46	36.82	1.28	2.55	0.73	1.46	0.73	0.36	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	36.07	29.70	1.59	2.65	1.59	2.65	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	25.81	25.81	1.20	3.60	1.20	1.80	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	26.58	38.40	3.61	1.64	3.28	1.97	2.30	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	24.23	34.80	1.30	4.72	3.42	0.98	0.81	0.16	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.80	52.03	2.29	1.23	2.65	1.59	1.23	0.35	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	32.35	29.54	1.41	2.81	0.70	0.70	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.90	24.82	4.14	0.92	0.92	1.38	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.10	29.56	1.93	5.14	1.93	1.93	0.64	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.59	46.56	3.45	3.79	4.14	1.38	0.69	0.69	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	78.38	96.08	12.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	44.11	50.13	3.12	2.01	2.67	0.22	0.89	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.59	22.44	2.54	3.39	0.85	1.27	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	21.12	1.42	2.85	2.14	1.66	0.95	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	30.91	33.48	0.86	4.72	3.00	0.43	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	45.65	41.99	1.67	5.33	1.33	1.00	0.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	53.65	86.11	4.06	4.51	2.25	0.45	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.82	20.63	2.78	1.59	4.36	1.19	0.00	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	31.57	19.50	2.79	1.86	0.93	0.93	0.93	0.00	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.62	25.35	2.27	2.27	1.51	0.38	1.14	0.00	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	46.60	36.50	1.63	3.26	1.96	0.33	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	44.01	60.57	1.74	3.05	0.87	0.87	0.44	0.87	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.85	66.49	1.81	3.17	6.33	0.45	0.00	1.36	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	31.75	3.53	0.00	1.76	1.76	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.26	18.62	1.33	1.33	2.66	1.33	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.72	32.24	0.50	2.98	1.49	1.49	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.92	34.84	3.06	2.68	1.91	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.38	12.70	0.30	1.21	1.51	1.81	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.89	38.68	3.09	1.77	2.65	0.88	0.22	0.66	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	21.68	2.03	3.39	2.71	2.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	25.55	5.11	0.00	0.00	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	34.75	1.22	0.61	1.83	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	34.62	37.77	3.46	3.78	2.83	1.26	0.31	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.96	37.23	1.82	2.72	1.82	0.61	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	23.73	0.79	4.75	0.79	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	31.74	48.75	3.40	2.27	4.53	0.00	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	40.46	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	49.07	20.75	7.08	2.61	2.36	1.49	0.37	0.50	0.25	0.00
Myoblast, donor2	11322-117D8	59.26	32.80	4.60	3.64	3.26	2.11	1.15	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	62.56	33.30	6.73	3.20	2.86	1.18	1.01	0.50	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	97.77	88.44	3.94	11.53	9.92	2.77	1.90	1.31	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	111.01	97.18	3.69	7.07	9.23	0.62	2.15	0.31	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	98.01	104.04	1.51	7.84	11.76	0.90	2.11	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	104.91	119.27	2.94	11.23	13.25	1.66	2.94	1.47	0.37	0.00
Neural stem cells, donor1	11275-116H6	111.06	76.58	1.45	1.81	3.99	2.54	0.73	4.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	130.94	103.98	3.85	1.93	0.00	0.00	0.00	3.85	3.85	0.00
Neurons, donor1	11494-119E9	101.27	96.72	5.69	7.97	2.28	3.41	0.00	3.41	1.14	0.00
Neurons, donor2	11574-120E8	111.62	107.00	3.08	5.94	1.76	1.98	1.10	5.28	3.08	0.00
Neurons, donor3	11655-122E8	73.17	148.81	2.47	8.22	5.76	4.11	0.82	8.22	2.47	0.00
Neutrophils, donor1	11233-116C9	59.39	209.73	1.86	10.21	3.71	0.00	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	43.48	211.62	0.00	0.00	2.90	2.90	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	66.58	312.75	1.83	2.44	2.44	1.22	0.61	1.22	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	64.47	44.41	1.42	2.26	1.07	2.85	2.26	0.83	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	67.73	54.70	0.65	2.28	2.28	3.26	1.30	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	74.81	43.32	1.20	1.00	2.21	3.81	3.81	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	44.60	49.14	2.75	3.99	1.79	2.20	0.69	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	50.52	55.44	4.34	3.62	4.20	2.03	2.03	0.43	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	47.22	46.76	2.95	2.61	2.50	1.36	0.57	0.91	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	67.79	42.95	2.73	1.95	1.46	1.66	0.58	0.58	0.39	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	122.77	54.77	4.21	1.81	2.41	1.20	1.20	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	48.49	23.61	3.40	1.91	1.70	1.91	1.06	0.43	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	40.01	26.29	4.57	4.57	0.00	0.00	3.43	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	73.24	39.10	0.62	3.10	4.34	0.00	3.72	2.48	0.62	0.00
Osteoblast, donor1	11277-116H8	41.63	18.18	2.54	2.54	0.98	0.39	0.98	0.98	0.39	0.00
Osteoblast, donor2	11354-117H4	74.45	44.95	2.11	1.40	1.40	2.11	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	63.98	38.92	4.98	4.09	1.60	1.60	1.78	1.24	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	61.83	23.50	2.19	1.26	1.35	1.60	1.26	0.59	0.17	0.00
Pericytes, donor1	11491-119E6	108.15	52.74	1.78	1.22	2.78	0.78	1.45	1.22	0.33	0.00
Pericytes, donor2	11571-120E5	93.26	64.29	2.49	3.40	3.40	1.58	4.75	0.45	0.68	0.00
Pericytes, donor3	11652-122E5	90.74	52.69	5.70	3.46	3.66	0.41	0.61	0.81	0.20	0.00
Perineurial Cells, donor1	11499-119F5	96.41	40.69	3.05	0.79	1.36	1.92	1.02	0.90	0.34	0.00
Perineurial Cells, donor2	11579-120F4	53.27	33.77	4.14	1.66	1.20	2.67	1.29	0.64	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	131.96	116.98	2.55	5.74	5.42	1.91	1.27	2.55	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	62.93	94.52	1.47	5.88	2.45	0.73	2.20	0.73	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	101.46	106.90	2.46	7.25	6.47	0.91	1.94	0.52	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	83.71	55.01	7.89	2.87	5.02	3.11	1.20	0.48	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	64.32	35.48	1.11	2.22	2.22	1.11	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	56.15	41.43	3.53	3.53	3.14	3.14	2.75	0.59	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	47.47	25.95	3.80	3.16	2.53	1.90	0.32	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	36.58	17.26	3.19	1.13	2.44	1.88	0.00	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.97	8.88	1.83	0.26	0.52	1.17	0.52	0.13	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	45.03	28.37	3.15	1.80	1.35	2.03	1.35	0.45	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	40.28	18.22	3.30	1.07	2.45	1.70	0.32	0.11	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	39.28	20.95	3.49	3.06	2.18	0.44	0.44	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	65.46	30.66	5.44	3.44	3.72	0.86	0.72	0.57	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	64.96	30.51	5.91	0.00	4.92	3.94	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	42.08	18.43	7.37	2.76	2.46	1.84	0.31	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	108.37	41.79	8.15	3.01	1.59	3.72	1.59	1.24	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	85.48	33.38	8.17	3.92	3.07	2.04	1.53	0.34	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	86.63	28.22	7.82	1.30	1.30	4.10	1.21	0.65	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	71.79	29.45	5.98	1.84	1.84	3.22	0.92	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	91.12	27.27	4.49	1.78	2.30	3.87	1.99	0.31	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	138.94	63.81	18.10	5.43	4.83	6.03	1.51	3.47	0.91	0.00
Prostate Epithelial Cells, donor2	11331-117E8	77.46	26.95	13.14	3.25	4.33	2.17	1.08	0.68	0.54	0.27
Prostate Epithelial Cells, donor3	11404-118D9	57.75	55.30	1.78	1.16	1.04	0.37	0.37	0.55	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	77.00	31.09	7.40	1.94	2.05	1.59	0.46	1.14	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	96.10	40.52	4.66	2.87	1.08	1.26	1.43	1.08	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	62.25	34.31	2.71	1.15	1.25	1.98	1.15	0.10	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	121.54	60.59	8.03	2.19	1.46	1.82	0.73	0.73	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	101.68	33.13	4.57	0.76	1.04	1.25	0.42	1.11	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	163.33	59.85	9.64	1.52	6.59	1.01	0.00	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	113.10	55.48	6.40	3.56	2.85	0.71	0.00	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	120.90	35.99	6.46	1.06	1.27	0.85	0.64	1.38	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	111.66	60.60	3.40	2.04	2.72	2.04	4.77	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	112.39	55.93	6.60	2.96	4.45	3.10	2.83	0.94	0.54	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	87.25	59.05	6.44	1.78	6.66	2.44	0.44	1.11	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	81.18	81.85	5.32	5.32	3.33	2.00	3.33	2.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	122.81	57.00	11.00	3.30	4.18	1.10	0.22	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	102.83	65.21	7.52	3.76	3.76	2.51	0.63	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	106.25	53.82	6.38	2.22	3.33	1.11	3.05	1.94	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	195.14	63.88	16.11	2.15	2.15	1.34	0.27	0.54	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	111.75	50.18	5.06	2.53	2.95	0.84	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	122.84	69.04	8.10	2.89	3.47	0.39	1.93	1.93	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	97.49	38.89	4.41	0.78	2.85	2.33	0.78	1.04	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	95.51	36.67	5.68	1.42	0.85	0.85	0.85	0.85	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	95.71	55.57	3.09	3.09	5.15	0.00	1.03	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	76.53	38.89	3.01	0.25	1.76	1.76	0.25	1.51	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	90.20	53.05	4.01	2.14	1.20	3.88	1.60	0.67	0.80	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	57.18	32.16	4.47	4.47	1.79	2.68	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.67	24.22	3.30	3.85	2.75	1.65	1.10	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.20	24.94	4.06	2.32	2.32	1.74	0.00	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	94.01	39.27	3.38	0.78	2.21	0.39	0.65	0.91	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	93.15	42.01	6.26	3.08	2.58	1.09	0.40	2.09	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	89.90	34.58	7.47	3.90	1.67	0.56	0.33	1.78	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	74.43	22.20	3.23	1.74	1.49	1.61	0.62	1.61	0.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	98.25	44.05	5.13	3.26	1.86	0.58	0.12	2.45	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	93.15	37.91	4.39	5.32	2.54	1.16	0.23	1.16	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	91.32	40.80	3.42	2.05	2.19	1.10	0.82	1.23	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	77.91	34.94	4.84	3.03	1.66	0.15	0.15	2.12	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	89.77	35.12	6.99	2.51	2.33	0.36	0.36	3.05	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	93.10	44.33	3.59	2.87	3.30	0.43	0.72	1.29	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	87.35	40.24	5.79	4.40	1.93	0.75	0.43	2.47	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	85.19	38.50	3.76	4.20	2.66	0.44	0.66	0.89	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	96.35	44.54	4.78	2.10	2.29	0.38	0.96	1.15	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	92.05	42.39	4.75	3.73	2.52	0.75	0.84	1.96	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	81.18	32.32	3.76	2.25	3.01	0.94	1.13	2.25	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	111.87	50.96	5.84	2.52	3.45	0.93	0.27	1.86	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	81.09	43.90	4.28	3.02	2.14	0.29	1.07	2.92	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	89.56	40.87	4.96	3.25	2.86	0.76	0.19	3.44	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	94.41	43.89	4.81	1.92	2.14	0.53	0.32	1.71	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	66.71	38.68	6.45	3.92	0.84	0.00	1.12	2.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	81.69	39.31	4.79	3.76	2.39	0.85	0.34	1.37	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	89.16	42.30	4.56	2.92	1.46	0.36	0.55	2.01	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	76.28	49.30	4.66	3.43	1.96	0.74	0.61	2.08	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	77.64	42.18	4.30	4.16	4.03	1.21	1.34	2.42	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	90.58	41.99	3.54	2.12	1.65	0.71	0.24	0.94	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	84.13	47.82	4.76	2.98	3.77	1.39	0.40	1.98	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	80.68	38.35	5.14	3.04	2.81	1.17	0.70	2.57	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.32	39.81	5.39	3.32	1.87	0.41	0.41	0.83	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	84.06	48.00	3.54	3.54	2.65	0.66	0.44	1.55	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	81.05	49.09	5.43	3.34	2.51	0.42	0.21	2.09	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	94.21	44.14	7.67	2.15	3.77	0.94	0.00	0.94	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	77.65	51.43	5.62	4.09	3.58	0.34	0.85	3.75	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	86.56	42.99	7.52	3.66	3.28	0.19	0.39	2.89	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	90.61	42.30	6.71	1.38	1.89	1.38	0.17	0.69	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	93.69	50.34	5.62	4.12	4.94	0.69	0.55	1.92	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	73.88	38.74	5.42	4.43	1.31	0.82	0.49	1.97	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	83.51	40.73	2.90	2.39	3.24	1.70	0.51	1.02	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	81.08	42.61	5.33	3.55	2.66	0.44	1.04	2.52	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	59.17	37.32	3.47	4.26	2.40	0.00	0.27	1.07	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	92.09	48.81	3.18	1.80	2.63	0.83	0.69	1.66	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	83.10	39.76	2.86	4.52	2.86	1.19	0.71	2.14	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	114.68	61.27	4.43	8.26	3.22	1.01	0.40	3.22	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	93.04	39.93	4.05	3.01	2.26	0.94	1.51	1.22	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	101.32	54.50	5.24	4.89	1.75	1.75	0.70	1.40	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	75.25	66.79	3.02	4.84	3.63	0.60	0.91	1.81	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	94.24	42.10	4.65	2.08	3.18	1.22	1.47	1.22	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	114.84	62.59	7.13	6.99	3.49	0.44	1.31	3.49	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	91.26	59.63	6.08	7.30	3.04	2.43	0.61	3.65	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	98.56	46.72	4.82	3.32	3.92	1.51	0.30	1.51	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	88.67	49.31	4.07	5.88	3.85	2.49	1.81	1.81	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	105.14	63.20	4.79	5.09	5.39	0.90	1.50	1.20	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	78.05	38.14	2.72	1.77	1.89	3.19	0.59	1.42	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	76.63	48.67	2.99	4.06	2.35	2.13	1.49	1.71	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.34	43.87	3.61	4.21	2.40	0.60	0.60	3.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	115.10	66.20	3.01	2.26	3.39	1.13	1.32	0.94	0.56	0.00
Schwann Cells, donor2	11578-120F3	68.05	54.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	81.50	47.76	4.60	3.51	1.97	1.10	0.88	0.66	0.88	0.00
Sebocyte, donor1	11220-116B5	159.95	47.66	18.62	3.83	2.19	0.55	0.55	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	78.58	27.57	11.49	2.30	3.22	1.38	0.92	2.30	0.46	0.00
Sebocyte, donor3	11378-118B1	88.42	44.73	6.80	1.86	2.89	0.82	0.41	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	71.23	28.16	8.28	4.97	1.66	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	42.37	19.77	5.65	5.65	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	67.74	52.43	1.58	1.76	1.76	1.06	0.70	1.76	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	33.97	14.46	0.72	2.17	2.17	0.72	0.72	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	78.59	33.44	2.51	2.51	0.84	0.84	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	90.49	36.45	3.46	0.94	2.04	4.40	2.20	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	83.24	33.15	2.82	1.49	2.53	3.72	1.19	0.89	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	112.81	42.94	3.23	1.54	2.31	2.77	1.23	0.46	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	85.31	39.94	3.02	2.02	1.51	4.41	1.26	1.13	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	85.04	47.09	2.43	3.28	2.14	2.43	2.71	1.28	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	108.83	49.60	7.74	3.47	2.68	2.18	1.69	0.69	0.50	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	71.02	40.53	5.56	2.02	2.78	1.60	0.42	1.52	0.67	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	58.62	27.50	2.90	4.34	1.45	0.00	0.72	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.45	20.23	1.24	1.65	1.65	1.51	1.51	0.00	0.41	0.00
Skin - palm, donor1	10286-104F7	88.64	37.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	87.07	33.44	12.69	2.02	5.62	0.58	0.58	0.72	0.58	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	86.70	30.26	14.72	1.64	2.45	3.27	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	91.53	39.34	10.52	2.60	1.82	2.99	0.13	0.65	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	88.41	46.43	13.34	1.11	2.92	0.97	0.83	0.97	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	98.32	77.50	14.35	4.36	3.38	0.14	0.70	1.13	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	75.70	31.29	12.48	1.69	1.90	1.69	0.21	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	97.06	72.63	7.50	2.62	1.42	0.52	0.67	0.90	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	105.23	47.52	10.18	2.16	4.01	1.23	2.78	1.23	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.36	13.12	2.00	0.89	1.56	0.67	1.11	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.38	20.57	7.05	0.59	2.35	0.59	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	39.12	25.64	5.75	3.31	1.77	0.22	0.66	0.44	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.19	23.23	3.54	1.58	2.36	1.18	0.39	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	40.17	22.40	0.77	0.00	0.77	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	48.04	36.03	0.00	0.00	0.00	4.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.64	18.23	4.66	1.33	1.46	1.06	0.80	0.40	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	75.36	46.33	3.55	4.43	3.99	3.10	1.55	0.89	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	61.20	23.94	4.35	3.07	1.79	1.66	1.02	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	65.12	30.93	2.60	1.63	2.60	2.28	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	77.67	33.96	4.73	2.36	1.18	3.54	0.59	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.65	28.19	3.99	2.28	1.57	1.14	1.28	0.71	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	124.93	38.72	5.69	1.30	1.63	1.46	0.49	1.46	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	52.97	48.10	0.91	1.22	0.61	1.83	1.22	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	45.71	25.76	1.77	1.01	2.02	1.26	1.01	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	50.07	23.84	1.91	0.48	5.25	1.91	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.21	29.35	3.69	0.88	0.74	2.95	1.18	0.74	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	55.53	38.10	4.52	0.65	1.72	2.80	1.72	0.22	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	68.64	35.37	4.83	1.47	1.47	1.47	1.15	0.52	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	45.48	20.26	3.56	1.24	1.70	0.46	0.46	0.62	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	31.26	18.32	1.08	3.23	9.70	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	46.62	15.24	1.49	0.30	0.90	0.60	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	106.18	52.23	6.83	1.71	0.34	0.00	0.68	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	76.17	36.04	2.36	1.10	1.18	2.43	1.73	0.39	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	81.22	42.57	6.74	2.82	2.62	1.71	1.21	1.81	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	73.04	39.37	9.10	4.10	6.83	2.05	2.05	0.68	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	39.25	15.70	2.42	1.21	2.42	3.02	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	117.63	55.10	8.48	2.65	3.44	1.06	1.59	2.38	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	86.29	37.02	4.66	2.13	2.00	2.26	1.60	0.27	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	64.86	49.96	4.26	1.75	3.01	2.38	1.88	0.75	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.05	25.37	1.27	1.27	2.03	4.06	1.52	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	64.83	27.44	4.98	2.26	2.41	1.36	0.90	0.15	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	34.51	27.76	3.75	0.75	0.75	2.25	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	217.09	130.51	16.80	0.00	16.80	1.29	6.46	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	53.95	22.32	1.40	1.40	2.33	0.93	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	65.13	40.90	3.03	1.51	3.53	2.52	1.01	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.94	18.80	6.27	2.51	3.76	0.31	0.00	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	68.44	27.73	3.83	2.06	1.18	1.77	0.29	1.77	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	132.71	49.40	6.33	1.83	2.25	2.08	1.50	1.00	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	55.59	35.50	1.87	0.93	0.93	1.87	2.80	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	50.95	23.03	4.61	1.73	1.73	1.30	1.15	0.58	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	54.56	39.01	3.82	2.04	1.78	1.02	1.53	0.76	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	53.03	21.62	2.44	2.26	2.63	1.50	0.94	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	84.41	37.03	4.05	0.84	1.26	1.82	0.98	0.98	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	90.41	35.69	3.44	1.84	1.51	1.34	0.92	0.59	0.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	90.47	39.52	0.48	0.48	1.43	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.87	20.80	3.91	2.45	2.45	0.98	0.73	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	60.98	42.42	9.28	2.21	1.99	3.09	2.87	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	56.47	21.94	2.34	0.88	0.88	2.34	0.29	0.59	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.87	41.98	1.55	1.75	0.58	2.53	1.36	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.71	17.45	2.12	1.59	2.64	0.26	0.26	0.79	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	14.51	1.86	0.74	0.37	3.35	1.12	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	40.96	18.33	1.80	1.44	3.23	3.23	0.00	0.72	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.28	17.89	4.26	1.14	1.99	0.85	0.85	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	72.47	40.17	3.54	1.58	2.76	2.76	1.58	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	30.47	18.03	0.51	0.25	0.76	2.29	0.76	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	65.09	33.54	0.80	0.40	0.80	2.40	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	30.93	18.81	2.09	0.42	1.25	0.84	1.25	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.50	19.71	0.92	0.92	1.38	2.29	0.92	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	67.16	38.71	6.23	4.21	3.70	3.03	1.18	0.67	0.17	0.00
Synoviocyte, donor2	11368-117I9	62.19	35.87	3.02	3.18	2.01	1.84	2.18	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	63.45	34.41	3.13	3.80	1.79	2.23	2.68	0.67	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	128.28	78.26	5.36	5.00	2.86	1.07	0.71	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	49.55	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	109.52	63.68	5.33	4.40	0.93	0.46	1.39	0.69	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	51.11	20.00	2.65	1.36	0.86	0.50	0.14	0.36	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	58.37	27.83	3.09	1.55	1.55	0.39	0.00	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	48.10	20.04	2.29	0.57	2.86	0.00	1.15	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	96.08	51.30	5.04	2.09	1.23	3.08	1.97	0.86	0.86	0.00
Urethra, donor2	10319-105A4	35.97	48.56	0.00	1.80	0.00	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	133.36	36.40	19.66	1.59	2.13	0.53	0.53	1.86	0.27	0.00
Urothelial Cells, donor2	11600-120H7	92.53	37.25	14.42	1.60	2.40	0.40	0.00	0.80	0.80	0.00
Urothelial Cells, donor3	11681-122H7	94.89	35.07	10.09	1.60	0.69	0.23	0.23	0.69	0.23	0.00
Urothelial cells, donor0	11216-116B1	110.56	41.68	7.36	1.34	0.67	1.11	0.00	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	124.57	172.62	0.89	4.45	2.67	4.45	2.67	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	170.12	161.55	0.00	0.00	0.00	4.29	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	93.78	130.74	2.74	8.90	1.37	0.00	0.68	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	91.94	106.40	3.10	6.54	2.07	2.07	1.03	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	92.38	97.61	3.49	2.32	2.91	2.91	1.16	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	133.28	163.47	2.08	3.12	0.00	1.04	5.21	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	133.08	134.00	2.75	4.59	0.00	0.92	0.92	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	74.86	117.76	3.65	3.65	0.91	0.91	2.74	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	109.05	87.96	13.20	3.95	7.53	4.69	1.60	1.85	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	55.44	58.08	2.64	1.76	0.00	0.88	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	136.31	47.20	5.59	1.68	1.96	0.56	0.56	1.40	1.12	0.00
achilles tendon, donor2	10292-104G4	20.67	35.13	0.00	2.07	4.13	4.13	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	154.50	48.19	31.36	9.94	7.39	5.10	0.76	2.80	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	111.44	82.89	8.82	5.11	5.11	3.71	2.55	1.16	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	161.21	61.02	4.75	4.99	4.04	3.32	1.19	2.02	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	114.02	65.04	3.27	10.34	7.35	5.71	0.82	1.36	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	53.97	29.51	4.22	3.09	1.97	1.12	0.56	1.12	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	52.02	35.53	4.65	2.96	3.81	2.75	1.27	2.33	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	33.75	34.57	2.18	3.54	5.17	0.82	1.63	1.09	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	80.20	57.28	1.76	4.85	3.08	3.53	3.97	1.32	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	62.48	60.85	2.45	7.76	3.68	4.49	2.86	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	79.60	103.68	8.93	8.93	10.48	4.66	2.33	2.33	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	79.12	75.07	3.50	3.31	2.94	2.02	2.21	1.66	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	85.81	7.80	11.70	0.00	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	107.36	59.49	3.95	6.27	11.85	9.06	4.65	1.16	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	129.45	91.91	8.28	6.99	5.44	1.04	1.04	2.33	1.29	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	107.84	95.27	4.97	2.92	2.63	2.63	0.58	2.05	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	84.59	80.87	6.51	2.32	6.51	1.86	0.46	0.93	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	52.64	42.36	1.65	4.52	0.82	2.88	2.06	1.23	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.65	135.06	4.60	9.52	7.06	0.31	0.61	1.53	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	91.74	104.97	9.39	3.41	6.83	1.71	2.13	2.13	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	89.47	94.63	10.01	4.85	5.46	1.21	2.73	2.73	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	99.89	97.97	7.70	3.61	5.05	1.68	1.68	2.41	0.96	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.07	54.57	6.01	4.23	6.01	3.12	0.67	1.56	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	79.05	71.38	7.67	3.67	7.67	0.33	0.00	1.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	107.78	33.45	1.86	7.43	3.72	9.29	0.00	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	38.80	30.89	1.51	0.75	1.51	2.64	0.00	0.38	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	87.23	125.61	4.36	10.90	12.65	2.18	3.05	0.44	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	157.45	459.24	13.12	28.12	13.12	3.75	0.00	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	117.28	43.10	9.66	4.00	1.65	2.12	0.24	0.00	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	68.87	44.52	1.86	1.86	0.78	2.79	1.09	1.24	0.31	0.00
adipose, donor1	10184-103D4	109.66	35.77	3.52	1.76	0.00	11.73	5.28	4.69	0.59	0.00
adipose, donor2	10185-103D5	105.84	143.15	1.62	4.06	1.62	3.65	2.43	0.81	1.22	0.00
adipose, donor3	10186-103D6	86.32	130.15	3.27	6.26	4.08	3.27	1.36	2.45	0.54	0.00
adipose, donor4	10187-103D7	117.88	121.35	10.40	4.33	10.40	5.20	6.93	1.73	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	106.53	85.85	4.10	2.53	1.10	1.26	1.74	0.79	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	36.38	32.74	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	105.66	67.10	6.00	3.74	3.60	2.80	1.60	1.20	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	134.34	97.54	13.93	10.72	5.72	7.86	3.57	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	76.28	38.49	3.25	2.78	2.55	2.32	0.70	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	69.99	45.31	1.69	1.01	1.69	2.03	1.69	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	73.94	31.82	2.95	0.88	2.36	1.77	0.59	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	126.88	106.72	5.93	3.56	3.56	1.19	2.37	1.19	2.37	0.00
amygdala, adult, donor10252	10151-102I7	97.53	68.13	2.23	5.07	2.23	1.42	1.42	2.03	2.03	0.20
amygdala, newborn, donor10223	10360-105E9	67.46	58.74	7.10	3.23	6.46	3.23	0.00	1.94	1.61	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	75.63	30.43	1.91	2.16	2.42	1.40	1.02	0.76	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	179.81	90.01	18.75	8.38	7.06	2.21	1.99	1.32	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	113.57	108.23	10.69	6.01	6.01	2.34	2.67	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	74.14	64.33	0.78	2.94	3.33	1.37	1.18	0.59	0.98	0.00
appendix, adult	10189-103D9	102.08	70.64	6.60	4.66	6.99	1.16	1.55	0.78	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	116.25	83.23	5.16	4.47	4.13	4.82	5.50	1.03	0.00	0.00
artery, adult	10190-103E1	95.11	59.78	2.72	0.00	2.72	1.36	1.36	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	60.12	54.33	2.17	4.06	1.74	1.16	0.87	1.88	0.14	0.00
b cell line:RPMI1788	10427-106D4	155.54	65.58	21.86	3.57	5.65	1.34	0.89	2.68	0.15	9.52
basal cell carcinoma cell line:TE 354.T	10702-109G9	45.78	35.51	1.94	2.50	1.39	1.39	0.28	0.83	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	154.21	55.57	18.16	2.58	3.77	1.29	0.89	1.69	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	57.41	85.03	4.02	3.35	4.35	0.50	0.67	1.00	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.84	95.07	4.47	5.59	2.80	0.56	1.68	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	115.49	61.71	2.06	0.98	0.87	0.98	1.20	0.76	0.43	0.00
blood, adult, pool1	10053-101G8	90.80	128.45	0.00	4.43	22.15	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	32.54	0.00	5.14	0.86	1.71	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	74.23	49.94	7.42	3.37	13.50	3.37	1.35	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	85.08	51.25	2.05	1.03	2.05	4.10	1.03	1.03	3.08	0.00
brain, adult, pool1	10012-101C3	115.92	68.71	3.67	2.78	1.78	1.34	1.34	2.12	2.12	0.00
brain, fetal, pool1	10085-102B4	101.51	128.23	0.00	8.01	2.67	0.00	2.67	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	88.54	79.29	6.61	4.63	8.26	0.99	1.98	1.65	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	142.80	83.51	7.61	2.00	2.00	0.25	0.37	1.62	0.25	0.00
breast, adult, donor1	10080-102A8	54.93	37.88	0.63	6.94	0.00	1.89	1.26	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	76.98	43.19	2.54	3.81	4.70	4.83	1.27	0.13	0.76	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	106.06	91.22	3.71	4.64	3.09	2.47	1.24	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	75.97	50.65	5.30	0.46	2.07	14.27	7.14	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	154.94	65.85	10.65	4.12	9.20	4.12	1.94	0.73	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	161.74	89.80	2.35	3.29	1.88	3.29	0.94	4.23	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	292.16	229.81	30.85	11.59	12.25	1.97	2.52	3.06	0.66	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	133.10	45.63	3.80	1.58	0.63	2.85	0.63	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	183.66	74.26	3.99	2.93	6.92	4.26	3.19	3.19	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	69.08	102.47	2.30	2.30	1.15	4.61	1.15	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	88.68	66.93	1.51	7.03	1.51	2.01	0.67	1.34	2.34	0.00
caudate nucleus, adult, donor10258	10379-105H1	93.99	74.12	0.76	6.11	3.06	0.00	0.76	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	46.51	56.40	3.30	3.30	6.23	2.56	1.83	2.20	2.56	0.00
cerebellum - adult, donor10196	10173-103C2	116.53	107.79	0.00	0.00	0.00	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	119.99	103.13	1.71	3.63	1.71	0.85	0.64	2.78	2.14	0.00
cerebellum, adult, pool1	10083-102B2	75.20	66.57	0.69	4.14	1.72	1.72	1.38	0.69	3.10	0.00
cerebellum, newborn, donor10223	10357-105E6	68.08	89.67	2.49	3.32	3.32	2.49	0.00	3.32	3.32	0.00
cerebral meninges, adult	10188-103D8	79.17	45.39	2.77	2.27	1.51	1.76	1.76	1.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	43.12	32.89	0.00	1.46	1.46	2.19	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	274.91	84.98	6.90	3.31	2.16	1.15	1.87	3.02	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	124.12	55.35	7.29	3.65	3.65	1.66	0.99	1.66	0.17	0.00
cervix, adult, pool1	10013-101C4	99.85	65.51	3.88	1.36	1.05	2.62	1.68	1.68	0.63	4.93
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	107.43	40.27	13.66	2.51	3.76	1.67	1.11	0.70	0.56	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	83.60	107.11	5.23	10.45	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	165.78	88.86	8.20	2.73	2.98	2.36	3.48	3.11	1.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	129.87	162.39	8.75	8.26	12.69	4.31	3.94	1.23	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	111.24	148.24	5.93	6.88	11.86	1.66	1.66	1.66	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	62.97	45.02	2.28	1.71	1.99	1.71	0.57	0.85	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	71.49	43.45	4.57	1.89	1.49	2.59	0.99	0.99	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	48.35	32.42	2.20	1.10	2.20	2.75	0.55	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	93.91	65.64	2.02	4.04	6.06	18.18	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	61.28	85.29	5.57	8.64	8.84	2.50	1.34	1.73	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.34	118.48	3.59	10.35	5.49	2.11	1.27	0.42	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	153.05	57.27	11.81	1.80	1.54	1.54	0.77	2.05	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	165.69	59.74	7.98	3.63	2.18	2.42	1.21	0.97	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	167.98	64.75	11.81	2.04	2.44	1.83	1.02	1.43	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	162.24	36.51	12.07	1.47	3.24	2.06	1.18	1.18	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	102.17	93.56	7.04	2.87	2.87	1.56	1.04	2.61	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	171.89	69.03	14.86	6.40	7.54	4.57	3.20	2.29	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	102.02	35.57	12.67	2.08	4.68	1.56	1.91	0.35	0.17	56.22
colon carcinoma cell line:CACO-2	10513-107D9	155.40	45.03	12.63	3.84	2.93	6.77	2.20	1.28	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	144.43	43.71	7.98	1.52	1.14	2.66	1.14	2.66	0.38	0.00
colon, adult, donor1	10082-102B1	117.81	89.25	4.76	4.76	1.19	2.38	2.38	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	92.95	50.53	4.94	2.59	2.23	2.94	2.00	0.59	0.71	0.00
colon, fetal, donor1	10070-101I7	50.68	44.50	0.62	0.62	2.47	1.24	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	87.09	137.51	0.00	9.17	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	75.11	0.00	25.04	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	89.24	37.39	18.27	5.10	5.10	2.12	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	100.07	32.30	18.87	2.57	4.38	2.41	1.06	0.45	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	115.63	30.74	18.05	2.68	2.96	3.24	0.99	1.55	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	146.27	69.99	1.99	2.21	3.10	1.99	1.33	4.09	5.64	0.00
cruciate ligament, donor2	10295-104G7	38.90	39.71	0.00	4.05	3.24	1.62	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	68.22	70.63	1.61	2.41	4.01	5.62	0.80	3.21	0.80	0.00
diencephalon, adult	10193-103E4	67.68	53.76	0.48	1.92	3.12	1.44	0.72	1.68	3.36	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	160.27	72.10	15.15	6.89	8.27	4.36	1.84	0.46	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	221.05	99.50	10.51	4.62	5.90	1.28	0.77	2.56	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	100.14	53.68	15.17	2.65	4.57	2.41	0.24	1.93	0.24	0.00
ductus deferens, adult	10196-103E7	73.75	60.30	5.98	4.98	3.49	1.50	1.00	1.50	1.00	5.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	67.69	84.97	1.44	7.20	2.88	0.00	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	77.24	70.62	2.94	1.47	2.94	7.36	4.41	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	102.57	84.32	2.31	2.23	3.72	2.15	1.24	1.57	1.32	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	58.85	75.06	11.55	13.77	27.76	2.00	1.33	4.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.52	50.01	14.47	2.29	4.73	2.72	0.43	3.73	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	86.94	98.66	3.08	2.47	0.62	0.00	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	55.09	23.61	1.51	1.51	0.91	1.51	2.12	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	99.11	108.06	3.40	5.87	2.78	1.23	0.93	1.23	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	72.24	80.12	2.63	5.25	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	95.87	38.55	9.39	2.01	2.01	0.34	1.01	0.34	0.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.21	43.50	1.81	3.62	0.54	1.45	1.09	1.45	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	179.47	46.80	36.67	3.22	14.79	3.70	1.61	2.41	0.48	2.09
epidermoid carcinoma cell line:A431	10426-106D3	115.72	66.58	11.34	2.11	3.33	0.67	0.67	0.78	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	90.85	42.34	8.25	3.19	3.52	1.10	0.99	1.32	0.22	0.00
epididymis, adult	10197-103E8	65.10	44.37	4.60	1.88	2.09	4.19	1.67	0.63	1.05	41.02
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	95.09	53.58	6.74	2.13	1.42	3.55	1.06	0.71	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	68.42	47.19	9.44	2.36	1.97	1.18	0.79	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	99.07	43.64	14.68	5.24	9.30	2.88	2.10	0.92	0.39	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	116.73	51.38	16.83	5.81	5.91	2.56	1.87	1.18	0.49	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	107.88	47.95	16.69	5.49	7.28	3.70	2.13	0.67	0.34	0.00
esophagus, adult, pool1	10015-101C6	124.55	54.79	6.90	1.81	1.17	2.12	1.17	0.42	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	135.88	100.19	6.26	1.88	1.88	1.38	2.25	2.25	0.50	0.00
eye - muscle inferior rectus, donor1	10272-104E2	45.88	91.75	2.41	2.41	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	50.50	42.08	2.10	2.10	6.31	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	46.13	44.65	2.98	5.95	10.42	1.49	2.98	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	52.74	27.52	3.44	2.29	1.15	2.29	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	36.43	0.00	0.00	5.83	1.46	1.46	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	70.17	66.86	1.53	2.03	2.03	2.29	2.54	0.76	1.27	3.05
fibrosarcoma cell line:HT-1080	10758-110E2	72.32	46.67	3.08	4.49	2.44	1.41	1.03	0.38	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	234.57	115.62	19.71	9.73	9.73	2.85	1.19	1.42	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	143.55	68.12	4.13	2.53	3.00	1.60	0.94	3.19	1.60	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	131.21	57.35	12.61	2.10	4.50	3.60	1.50	1.50	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	81.01	31.64	3.57	0.55	0.46	1.28	0.55	0.73	0.00	0.00
gall bladder, adult	10198-103E9	65.43	52.39	2.66	1.93	1.93	1.45	1.93	0.24	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	94.49	82.68	1.07	8.05	2.68	6.44	1.07	1.07	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	95.24	80.67	1.49	8.96	4.11	3.36	0.37	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	109.62	44.14	6.97	1.90	3.59	1.27	0.21	1.06	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	108.51	126.49	4.84	4.26	4.06	1.74	4.26	0.19	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	92.80	58.70	5.90	3.44	2.46	5.57	2.46	1.15	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	88.78	40.27	2.75	2.75	1.83	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	192.36	100.52	12.11	4.57	11.65	2.97	2.06	2.28	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	86.97	37.18	1.72	1.61	0.57	0.46	0.46	1.26	0.57	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	117.57	55.14	3.22	1.54	2.10	0.98	1.12	2.10	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	100.52	68.34	12.47	8.23	5.49	1.25	1.00	2.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	99.01	29.87	11.08	2.11	1.16	0.74	0.32	0.84	0.42	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	93.67	32.16	11.09	3.51	2.39	0.56	0.28	0.98	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	103.20	61.70	5.52	2.21	1.77	5.19	0.77	0.33	0.00	0.00
glioma cell line:GI-1	10413-106B8	55.06	50.37	5.56	3.81	4.69	0.88	0.88	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	59.04	84.55	0.73	4.37	0.73	1.46	2.19	0.73	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	103.50	66.15	3.91	3.66	2.93	2.93	1.71	2.44	2.69	0.00
globus pallidus, adult, donor10258	10367-105F7	69.83	91.74	0.00	8.22	5.48	0.00	0.00	4.11	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	55.96	51.69	3.73	3.73	5.33	2.13	0.53	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	115.02	171.30	7.34	12.24	9.79	0.00	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	120.21	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	109.76	5.23	15.68	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	84.48	47.68	3.52	2.56	1.60	1.28	0.96	0.96	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	204.31	103.76	8.26	4.59	2.75	4.59	0.00	1.84	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	184.28	88.71	10.06	1.83	5.94	7.32	0.46	2.74	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	201.60	114.00	10.95	3.22	5.15	7.73	0.00	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	110.67	110.67	1.44	1.44	2.87	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	175.58	120.71	6.86	1.37	4.12	2.06	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	81.66	83.86	0.00	0.00	3.31	1.10	0.00	2.21	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	204.01	56.61	25.29	5.75	11.78	2.59	1.72	3.16	0.00	7.47
heart - mitral valve, adult	10205-103F7	74.14	36.47	1.49	3.89	2.09	1.49	1.49	1.49	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	105.11	60.14	2.61	1.05	1.05	3.14	1.31	0.78	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	91.59	45.80	0.83	4.16	3.33	1.67	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	86.93	65.50	3.88	3.47	5.10	1.84	0.82	0.82	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	89.85	68.56	2.98	4.68	2.13	0.85	0.85	1.70	0.85	0.00
heart, adult, pool1	10016-101C7	90.38	53.81	4.14	4.83	2.30	2.07	1.61	0.69	1.15	0.00
heart, fetal, pool1	10046-101G1	190.47	71.47	4.11	4.11	2.05	2.26	2.88	3.18	1.54	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	71.58	63.25	3.39	4.01	1.85	1.85	0.62	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	105.84	122.49	8.32	4.76	11.89	2.38	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	116.57	82.54	19.12	8.40	10.94	2.65	1.99	1.22	0.44	5.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	119.43	79.99	18.21	6.92	8.37	3.03	2.43	1.70	0.73	5.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	119.55	80.74	18.19	6.67	9.60	3.94	1.92	1.21	0.61	9.80
hepatoma cell line:Li-7	10484-107A7	151.48	65.06	9.01	3.00	1.00	1.89	0.67	2.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	110.65	107.03	11.36	5.73	7.94	2.91	2.41	2.11	0.50	0.10
hippocampus - adult, donor10196	10169-103B7	98.42	90.85	0.95	4.73	1.89	3.79	0.00	0.00	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	91.44	72.66	2.65	5.10	1.84	1.63	1.02	3.27	2.25	0.20
hippocampus, adult, donor10258	10374-105G5	76.19	81.66	1.99	1.00	2.99	0.50	0.00	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	57.10	63.09	2.11	2.82	3.17	2.11	0.35	1.41	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	169.68	64.70	15.87	4.27	5.49	14.04	3.05	2.44	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	180.84	86.20	14.53	4.91	5.69	4.32	0.98	3.73	1.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	204.89	47.48	16.25	2.54	2.79	4.06	2.03	4.06	2.54	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	162.96	84.58	3.38	1.13	1.13	10.15	1.69	5.07	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	165.26	73.85	2.07	2.07	0.77	6.97	2.32	4.13	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	184.49	59.98	2.28	0.38	2.28	3.42	1.14	1.90	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	88.17	67.44	2.04	2.63	2.34	4.38	1.46	2.63	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	102.97	107.93	1.94	4.52	3.02	4.09	3.02	4.31	2.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	95.51	86.75	4.59	8.76	2.09	3.34	1.67	3.75	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	88.56	85.01	4.50	3.32	2.13	2.60	0.95	3.32	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	82.61	102.86	2.57	6.27	3.54	2.25	1.77	4.18	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.16	84.16	2.02	4.71	6.73	3.37	0.67	2.69	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	145.84	61.65	9.70	5.01	3.60	4.69	2.66	4.38	4.07	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	137.07	57.48	5.40	2.95	4.42	8.35	0.00	1.97	3.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	79.42	31.42	12.22	0.87	2.62	6.98	0.87	6.11	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	176.40	90.30	4.96	2.67	1.53	3.82	2.10	3.25	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	150.88	90.27	3.05	1.74	2.18	3.92	1.31	1.74	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	177.42	51.48	5.50	0.50	1.00	7.00	0.00	4.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	124.53	75.36	1.32	0.94	1.51	2.64	0.57	2.07	2.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	105.49	105.49	0.91	1.36	2.27	4.09	0.00	3.64	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	127.49	86.77	2.19	1.57	0.94	3.76	0.63	2.51	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	78.06	109.74	2.61	7.68	4.74	3.43	1.80	3.10	1.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	87.96	127.16	4.64	6.39	3.19	4.64	2.61	2.90	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	92.37	98.94	4.78	5.08	3.89	3.89	0.60	3.59	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	171.07	73.90	10.35	4.06	2.77	4.43	1.85	3.51	2.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	193.71	91.29	8.56	3.14	5.14	4.56	2.28	2.00	2.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	169.86	48.18	22.05	4.49	4.08	6.94	5.72	1.63	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	133.79	86.26	4.58	3.17	2.46	5.99	2.11	0.70	1.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	133.03	90.59	3.17	3.48	1.58	3.48	1.58	2.53	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	140.72	72.02	7.26	4.24	1.82	4.54	2.42	1.51	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	96.70	85.33	1.03	2.59	1.03	1.55	0.00	0.52	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	100.29	108.26	0.66	8.63	1.33	4.65	1.33	1.33	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	76.70	54.38	3.85	1.03	1.03	3.33	0.77	3.59	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	82.83	80.53	2.81	5.62	2.56	2.05	1.79	3.32	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	61.34	97.68	1.51	6.06	3.79	1.51	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	90.74	85.69	3.36	3.02	2.35	3.70	1.68	2.02	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	203.59	79.46	9.90	5.07	4.11	3.86	1.93	2.66	2.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	219.71	52.59	16.04	3.12	4.01	11.59	2.67	4.90	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	214.15	82.93	13.66	3.41	3.90	5.85	1.95	1.95	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	169.62	88.63	2.75	2.75	1.22	3.97	1.22	1.83	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	104.10	58.56	3.25	0.00	3.25	26.03	13.01	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	116.16	39.71	4.63	1.32	1.32	8.27	3.31	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	94.68	125.88	1.64	2.19	2.19	2.19	0.55	2.74	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	100.60	93.00	3.62	1.09	0.72	2.53	0.72	2.53	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	92.17	80.78	3.56	1.42	2.49	4.98	2.49	3.56	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	91.89	112.18	1.19	4.77	1.19	1.19	2.39	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	121.88	123.37	6.23	4.20	2.57	3.66	1.08	3.39	1.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	96.71	98.60	6.47	5.66	3.77	2.96	1.62	2.69	0.81	0.00
immature langerhans cells, donor1	11904-125F5	30.99	72.16	3.63	4.12	3.63	1.21	0.48	0.48	0.24	0.00
immature langerhans cells, donor2	11905-125F6	41.19	60.20	2.38	3.96	7.92	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	160.12	76.27	6.44	3.50	1.42	1.32	1.23	3.31	1.80	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	65.03	61.78	5.85	3.25	5.53	2.93	0.98	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	101.53	54.27	12.32	3.10	3.00	2.70	1.10	1.50	0.50	1.10
kidney, fetal, pool1	10045-101F9	116.08	65.86	6.37	2.19	3.18	1.91	0.92	2.33	0.64	9.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	176.67	76.41	12.78	3.83	4.26	2.27	2.56	1.28	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	70.09	29.45	2.63	1.66	1.66	1.66	1.94	0.97	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	135.42	71.01	4.22	2.39	4.77	0.55	0.55	1.83	0.18	0.00
left atrium, adult, donor1	10079-102A7	34.33	71.92	1.09	3.27	2.18	2.18	1.09	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	62.70	77.37	2.02	4.05	3.54	2.53	1.52	0.51	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	100.69	95.49	10.40	2.46	4.65	1.37	0.27	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	54.25	20.84	3.59	1.80	1.44	2.16	2.16	0.36	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	50.00	19.02	2.72	3.26	2.17	0.54	1.09	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	60.46	26.95	2.91	2.19	1.46	3.40	1.70	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	0.00	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	99.33	63.78	13.59	0.00	2.09	2.09	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	148.75	141.79	13.22	16.76	11.22	2.36	2.13	2.01	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	41.24	31.24	2.97	2.66	2.19	3.91	2.19	0.62	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	56.53	81.27	3.53	5.36	2.44	2.31	1.10	1.58	0.49	0.00
liver, adult, pool1	10018-101C9	88.65	36.46	9.24	1.46	0.65	1.94	0.81	0.49	0.97	0.00
liver, fetal, pool1	10086-102B5	68.67	30.10	1.88	10.35	5.64	1.88	2.82	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	85.89	63.14	2.48	4.96	3.94	1.17	0.73	2.62	1.90	0.15
locus coeruleus, adult, donor10252	10165-103B3	89.69	66.44	2.77	5.35	3.88	1.66	0.92	2.03	2.21	0.37
locus coeruleus, adult, donor10258	10375-105G6	71.10	62.35	2.26	5.64	5.92	1.69	0.56	0.56	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	34.49	36.59	3.36	0.84	2.94	4.63	0.84	1.68	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	59.92	61.45	5.26	3.60	3.18	0.97	1.94	0.42	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	164.77	42.05	15.17	0.69	0.69	0.00	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	136.43	80.41	7.78	1.32	1.45	1.32	1.71	1.71	0.53	0.00
lung, adult, pool1	10019-101D1	117.30	59.06	2.36	2.60	0.71	2.01	1.77	0.71	0.47	0.00
lung, fetal, donor1	10068-101I5	103.03	57.94	1.71	0.29	2.85	2.57	1.71	0.86	1.43	0.29
lung, right lower lobe, adult, donor1	10075-102A3	59.57	92.10	1.37	5.50	4.12	4.58	1.83	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	73.84	107.93	2.37	5.68	6.63	2.37	5.21	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	140.27	121.21	20.38	13.81	12.71	2.41	2.41	2.85	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	106.86	30.49	11.47	6.19	4.08	4.83	3.02	1.66	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	168.20	79.85	34.83	5.10	8.49	0.85	2.55	3.40	0.00	0.00
mature adipocyte, donor1	12231-129F8	47.51	42.18	0.44	1.33	0.89	0.89	1.78	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	55.20	41.71	3.32	2.70	1.04	1.25	1.25	1.04	0.21	0.00
mature adipocyte, donor3	12233-129G1	49.55	41.01	2.37	2.37	1.19	1.42	1.90	1.90	0.24	0.00
mature adipocyte, donor4	12234-129G2	50.54	45.27	1.05	1.32	0.53	1.84	0.53	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	121.99	103.17	8.10	3.57	4.05	1.43	1.19	1.91	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	90.24	80.09	1.13	7.90	0.00	1.13	1.13	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	88.83	75.03	4.60	5.15	3.13	0.92	1.10	1.84	1.29	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	97.85	91.18	3.49	3.81	3.49	2.86	0.64	1.27	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	46.06	37.96	3.84	1.71	4.26	1.71	0.43	2.99	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	123.69	92.81	5.23	4.56	3.88	3.04	0.51	1.52	1.18	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	93.17	76.40	2.33	4.88	4.67	0.64	0.64	1.49	1.49	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	80.90	1.93	3.85	3.85	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	43.06	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	68.56	55.28	8.61	3.95	3.59	2.51	1.79	2.15	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	50.62	68.79	3.24	2.60	5.84	4.54	0.00	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	83.75	61.92	2.17	3.72	2.17	1.70	1.39	0.93	2.01	0.46
medulla oblongata, adult, pool1	10038-101F2	108.48	58.69	3.84	2.86	2.61	2.04	0.57	3.10	4.65	0.00
medulla oblongata, newborn, donor10223	10361-105F1	66.31	54.51	3.12	1.74	2.78	1.39	1.39	3.12	4.51	0.00
medulloblastoma cell line:D283 Med	10838-111E1	164.07	68.19	5.98	1.55	1.55	2.21	0.66	2.44	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	97.21	117.38	7.34	10.52	7.21	0.49	0.73	1.10	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	51.17	67.85	6.47	9.34	8.05	2.44	1.58	1.44	0.00	0.00
melanoma cell line:G-361	10465-106H6	53.75	37.73	3.26	3.26	1.63	1.09	1.36	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	68.74	41.25	3.08	1.45	2.35	1.27	0.90	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	195.62	92.52	6.17	6.17	1.76	1.76	0.88	0.88	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	84.51	35.00	1.81	3.89	1.04	0.00	0.26	3.11	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	71.65	22.71	4.91	1.99	1.84	4.14	3.22	0.46	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	56.53	25.99	4.18	1.27	1.82	1.64	1.27	0.18	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	52.59	17.81	2.90	1.66	2.90	1.24	0.41	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	50.43	15.59	0.98	0.84	0.98	2.39	1.69	0.14	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	56.04	14.83	2.31	0.58	1.16	2.31	1.93	0.77	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	47.89	13.88	4.86	1.39	0.69	0.69	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	59.56	21.28	2.23	2.40	1.89	1.20	1.54	0.51	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	61.53	18.86	3.34	0.92	1.15	1.96	2.07	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	62.87	20.16	3.45	1.06	1.59	2.65	0.93	0.40	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	71.30	20.12	4.05	0.68	2.16	1.89	1.49	0.54	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	70.14	20.06	6.69	0.71	1.14	2.13	1.99	0.28	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.13	28.00	2.96	0.99	0.99	0.99	1.65	1.32	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	60.47	22.83	4.01	0.42	0.97	2.77	1.11	0.42	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	78.19	35.26	2.09	1.05	1.40	3.14	1.75	1.05	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	67.37	21.23	4.08	1.02	1.22	1.84	1.02	0.61	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	33.43	16.53	3.95	0.72	1.80	1.44	1.08	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	60.62	20.28	2.28	0.52	0.52	2.07	2.48	0.10	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	38.99	18.47	3.88	0.91	2.28	0.68	0.23	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	62.93	21.82	5.45	0.84	2.52	3.36	0.42	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	47.97	19.73	2.99	1.94	1.20	1.64	1.79	0.30	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	61.01	21.44	5.34	1.58	1.93	1.49	1.75	0.53	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	55.59	13.99	2.21	1.47	0.74	2.58	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.49	18.03	3.43	1.14	2.00	0.29	0.00	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	71.15	37.89	5.47	4.21	6.74	3.79	1.68	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	54.34	31.05	1.37	0.46	1.37	3.20	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	52.69	29.42	1.79	1.53	0.51	2.56	0.51	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	45.81	30.89	2.36	2.36	1.57	2.36	0.79	0.52	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	51.45	34.51	2.16	3.08	0.31	2.46	1.23	0.92	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	47.78	32.95	2.12	0.94	1.18	2.59	1.88	0.47	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	51.11	36.21	2.71	3.05	1.35	2.37	1.69	0.68	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	47.94	31.44	1.96	1.57	1.57	2.36	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	44.95	26.88	2.32	1.39	0.46	1.85	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	60.28	32.59	1.15	3.17	1.15	1.73	1.44	0.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	53.77	34.13	2.23	1.34	1.34	2.68	0.67	0.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	44.71	36.05	0.72	1.92	2.40	2.16	1.44	0.48	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	54.27	55.73	1.47	3.67	0.73	1.47	3.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	49.01	32.89	1.68	1.34	1.01	1.68	0.67	0.67	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	43.39	19.24	1.64	1.23	1.64	0.41	0.82	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	42.53	32.65	2.58	2.58	0.86	3.44	2.15	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	30.08	2.73	0.00	8.20	5.47	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49	0.00	5.16	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.18	18.19	0.65	1.95	1.30	1.95	0.97	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	23.28	1.45	1.45	1.45	2.91	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	39.98	20.26	2.13	2.13	1.07	4.26	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	30.26	22.90	0.00	0.82	0.00	2.45	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	33.82	23.71	0.78	2.33	2.33	2.72	1.94	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	29.38	2.10	0.00	2.10	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	21.86	0.99	0.00	0.99	4.97	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	4.77	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	27.28	17.79	1.19	0.59	0.59	1.78	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	17.06	1.22	2.44	0.00	1.22	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	23.44	0.00	0.63	2.53	0.63	1.27	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	18.28	0.34	2.41	0.34	2.07	1.38	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	19.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	19.96	0.00	3.99	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	30.99	0.00	0.00	0.00	3.44	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.56	24.04	0.00	3.26	0.81	1.63	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.13	30.98	1.59	1.59	0.00	1.59	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	31.83	2.36	0.59	0.59	1.18	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.11	27.12	0.31	4.05	0.94	1.87	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	37.43	2.67	0.00	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	16.56	1.18	1.18	0.00	4.73	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	30.82	0.00	0.00	7.70	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	32.35	24.78	1.38	2.07	1.38	0.00	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	32.16	31.67	1.48	1.98	0.49	2.97	1.98	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	37.01	0.00	1.12	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	32.44	44.52	1.91	1.91	1.27	2.54	0.64	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.43	35.06	4.03	3.22	2.82	3.63	2.82	1.21	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	32.71	0.00	6.54	2.18	0.00	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	31.68	0.00	2.53	2.53	5.07	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.09	48.55	4.25	4.25	2.43	1.21	4.86	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	72.30	4.52	9.04	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.13	54.36	4.94	3.29	2.47	1.65	1.65	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.41	21.23	1.19	1.79	0.40	3.17	1.59	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.91	22.39	1.95	1.62	1.30	2.92	0.97	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	18.34	3.06	3.06	0.00	1.02	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	21.66	28.63	2.32	0.77	0.77	1.55	0.77	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	286.09	109.85	14.88	3.54	1.89	0.94	0.24	2.60	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	75.99	60.00	12.28	4.63	7.65	3.94	1.16	0.46	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	42.74	21.37	4.27	0.00	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	113.64	48.50	21.58	4.21	2.98	1.54	0.31	1.23	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	260.09	128.68	38.13	10.44	9.31	3.86	1.36	1.59	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	98.52	46.69	9.53	3.18	3.42	1.22	1.22	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	88.35	57.35	9.96	6.20	3.54	2.88	0.44	0.66	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	123.78	192.90	16.29	16.82	23.13	2.63	2.89	0.79	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	90.22	50.22	7.66	5.96	5.45	2.38	1.53	0.51	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	93.78	61.68	8.34	3.03	6.32	3.03	0.76	1.77	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	63.56	47.62	4.97	2.48	3.52	1.04	0.41	0.62	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	93.43	50.03	11.26	4.64	6.29	2.82	1.16	1.49	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	71.49	51.04	15.57	5.25	8.51	2.53	1.63	0.36	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	89.17	35.36	7.17	2.22	4.10	2.39	0.85	0.85	0.68	0.00
mesothelioma cell line:NCI-H28	10845-111E8	121.38	44.28	15.01	5.85	3.56	3.82	3.56	1.53	1.02	0.00
mesothelioma cell line:No36	10857-111G2	77.64	44.69	6.85	2.94	1.63	0.65	0.00	0.00	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	98.90	33.60	12.73	1.90	4.06	0.54	0.54	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	32.43	28.98	0.77	1.54	1.15	2.11	0.38	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	48.48	28.70	0.98	1.71	0.73	1.34	0.49	0.24	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	57.25	44.33	0.72	1.79	1.44	1.97	1.08	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	104.80	69.87	3.92	3.26	3.92	0.98	1.31	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	41.12	30.94	1.48	3.18	1.06	1.70	1.48	1.06	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	153.65	177.84	12.90	14.74	7.37	0.00	1.38	1.15	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	98.95	76.50	14.65	7.23	8.75	3.81	1.52	0.95	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	63.20	74.10	2.03	6.65	2.40	0.74	2.03	1.66	0.00	0.00
myeloma cell line:PCM6	10474-106I6	84.01	61.28	2.97	3.36	3.36	1.78	0.79	0.40	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	124.79	55.29	8.12	5.07	2.03	1.01	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	74.73	41.58	3.14	4.90	1.96	0.98	0.00	1.37	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	58.72	39.56	1.34	0.22	0.78	0.22	0.22	0.56	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.83	41.18	1.62	0.59	0.15	0.22	0.37	0.96	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	85.01	55.20	4.97	5.52	3.31	0.00	0.00	1.10	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	135.97	96.40	5.98	3.45	1.84	0.69	1.15	3.68	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	113.19	73.34	6.74	4.30	1.87	2.06	0.75	3.93	1.68	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	91.95	95.32	3.59	7.80	1.90	1.48	0.21	1.69	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	157.28	89.26	2.80	3.35	2.98	1.30	0.37	3.17	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	81.84	65.71	0.71	3.56	2.61	1.42	3.32	1.19	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.26	67.95	1.27	3.33	2.06	2.22	2.85	0.63	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	59.17	35.82	1.61	2.21	1.21	2.01	1.61	0.40	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	144.32	159.58	2.54	5.09	4.45	1.27	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	73.46	74.26	3.99	5.86	4.26	1.33	0.27	0.80	0.53	0.00
neutrophil PMN, donor1	12133-128D9	89.25	163.62	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	106.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	123.12	0.00	0.00	18.94	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	203.45	83.88	14.71	3.38	3.04	4.40	1.18	1.01	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	83.25	59.24	5.60	4.00	1.60	0.00	1.60	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	55.46	53.54	2.24	2.89	1.60	2.56	0.64	0.64	1.60	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	58.86	31.01	4.20	2.10	2.10	2.36	1.58	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	137.05	74.80	4.50	3.66	3.00	1.87	0.66	2.81	3.28	0.00
occipital cortex - adult, donor10196	10172-103C1	80.35	96.84	6.18	4.12	4.12	2.06	0.00	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	94.46	63.87	3.49	4.03	3.49	0.81	1.34	1.61	2.15	0.00
occipital cortex, newborn, donor10223	10355-105E4	83.34	42.22	4.37	2.91	5.10	1.46	0.73	1.46	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	73.21	40.67	1.31	4.46	2.36	1.31	1.57	1.05	1.31	0.00
occipital lobe, fetal, donor1	10073-102A1	73.81	133.88	0.00	4.29	2.15	3.43	3.43	2.57	3.86	0.00
occipital pole, adult, pool1	10036-101E9	114.87	62.68	3.78	2.84	3.47	0.63	0.79	2.29	2.52	0.00
olfactory region, adult	10195-103E6	97.82	66.10	1.72	3.06	2.87	0.96	0.57	1.34	2.29	0.00
optic nerve, donor1	10277-104E7	54.03	106.06	6.00	0.00	6.00	2.00	2.00	2.00	12.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	98.07	27.91	6.72	3.42	2.62	1.71	1.71	0.80	0.46	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	124.33	28.16	1.92	0.69	0.27	0.41	0.69	0.96	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	104.81	47.58	5.08	2.54	2.20	2.03	1.35	0.85	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	164.25	78.78	7.74	7.85	6.24	1.16	1.96	1.04	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	47.03	42.92	2.65	5.29	1.76	0.59	0.59	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	239.19	114.92	14.95	6.54	4.67	0.93	0.93	2.80	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	74.86	43.47	8.06	2.54	4.67	3.18	0.85	1.06	0.21	0.00
ovary, adult, pool1	10020-101D2	78.27	67.44	1.92	1.31	0.79	1.22	1.05	2.27	2.45	3.76
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	61.05	35.38	3.12	2.38	0.37	0.37	0.00	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	107.23	56.44	2.82	5.64	1.88	1.88	1.88	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	105.11	125.79	6.99	12.86	10.62	3.91	4.47	1.12	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	93.35	41.91	6.98	4.94	3.07	2.38	0.17	1.19	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	92.23	33.78	5.30	1.99	2.15	1.16	0.66	0.66	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	140.49	67.36	5.77	3.11	4.03	1.92	1.28	3.75	2.65	0.00
parietal cortex, adult, donor10258	10373-105G4	61.66	82.94	1.47	2.20	4.40	2.20	0.73	1.47	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	87.46	70.54	2.82	1.88	2.82	0.00	0.94	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	77.82	70.97	2.28	3.99	3.42	1.14	0.57	2.28	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	138.08	65.47	6.08	4.05	3.17	2.11	0.79	3.52	2.29	0.00
parietal lobe, fetal, donor1	10072-101I9	60.13	157.11	1.94	3.88	5.82	0.97	3.88	1.94	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	78.88	46.73	10.84	3.74	2.99	1.12	0.37	1.87	1.87	0.00
parotid gland, adult	10199-103F1	64.75	47.48	1.85	1.23	3.08	3.70	1.23	0.62	1.23	0.00
penis, adult	10200-103F2	66.60	58.55	1.61	1.61	0.54	4.30	2.15	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	80.32	78.47	0.37	2.79	0.93	1.49	0.74	1.49	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	120.49	107.52	10.49	3.50	5.68	4.23	2.77	0.73	1.02	0.00
pineal gland - adult, donor10196	10179-103C8	63.86	67.73	0.65	5.16	1.94	1.29	0.00	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	92.98	98.90	2.37	3.55	0.59	2.96	0.00	1.18	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	70.23	51.42	2.51	5.02	2.51	2.51	1.25	1.88	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	105.23	102.19	3.04	2.02	0.00	1.01	0.00	1.01	5.06	0.00
pituitary gland, adult, donor10252	10162-103A9	108.93	105.80	2.61	3.13	2.08	2.08	0.00	2.08	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	69.80	67.25	3.40	3.40	1.70	5.11	0.85	3.40	3.40	0.00
placenta, adult, pool1	10021-101D3	68.59	65.15	4.09	3.23	2.04	2.04	0.97	0.75	0.54	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	163.68	47.41	9.80	2.65	4.50	3.31	3.18	1.46	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	59.14	29.42	4.05	2.49	1.56	1.40	0.93	0.62	0.31	0.00
pons, adult, pool1	10033-101E6	118.86	50.61	4.73	2.15	3.87	1.81	1.03	2.67	2.24	0.00
postcentral gyrus, adult, pool1	10032-101E5	122.05	75.49	6.19	3.49	4.71	0.78	0.61	2.70	1.83	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	119.21	6.27	4.18	8.37	0.00	0.00	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	71.60	0.00	0.00	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	70.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	131.39	27.97	7.28	2.04	2.62	1.46	1.02	1.02	0.44	0.00
prostate cancer cell line:PC-3	10439-106E7	144.66	93.47	8.53	5.63	5.45	1.82	2.72	1.27	0.54	0.00
prostate, adult, pool1	10022-101D4	85.16	53.87	2.72	1.63	0.82	1.45	1.90	1.00	1.00	0.63
putamen, adult, donor10196	10176-103C5	113.78	103.63	1.42	8.26	2.12	1.65	1.42	2.60	1.89	0.00
putamen, adult, donor10252	10152-102I8	60.78	33.33	0.00	0.00	0.00	0.00	1.96	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	66.66	91.80	3.28	4.37	2.19	0.00	0.00	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	87.95	84.32	2.17	4.11	1.45	1.69	0.24	1.69	1.45	0.00
putamen, newborn, donor10223	10365-105F5	22.49	40.48	3.00	2.25	1.50	3.00	1.50	1.50	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	107.06	91.06	9.60	4.36	3.78	0.58	0.58	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	72.33	75.11	0.00	2.78	1.39	0.00	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	123.38	26.92	20.14	1.91	2.54	2.76	1.48	1.48	0.00	6.36
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	174.80	16.15	12.84	0.00	0.00	1.24	0.41	1.24	0.00	7.87
retina, adult, pool1	10030-101E3	89.56	82.50	3.48	2.78	1.89	2.29	1.39	1.69	1.69	0.30
retinoblastoma cell line:Y79	10475-106I7	104.96	55.08	3.90	2.08	1.56	1.56	2.34	3.12	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	87.17	83.48	3.93	2.58	2.21	2.34	1.11	1.11	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	140.32	91.11	6.75	3.09	1.41	2.53	0.84	1.12	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	117.47	93.97	2.27	3.79	1.52	1.52	1.52	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	93.88	39.17	3.72	1.13	0.97	1.13	2.27	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	70.36	47.92	2.89	0.96	2.07	2.75	3.58	0.41	0.14	0.00
salivary acinar cells, donor3	11773-123I9	108.58	129.10	4.63	7.94	3.31	1.32	1.32	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	102.38	69.21	5.72	0.57	1.14	1.14	1.72	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	90.21	36.25	3.96	2.61	1.52	1.10	0.59	1.10	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	84.40	43.85	4.23	2.70	1.76	0.82	0.71	1.76	0.12	0.00
seminal vesicle, adult	10201-103F3	57.14	70.90	8.47	4.76	3.17	4.23	1.06	0.00	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	100.09	46.40	9.72	2.43	2.43	3.89	2.19	0.97	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	80.77	37.74	5.79	5.54	7.30	1.51	0.50	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	114.40	45.16	6.02	2.01	7.02	5.02	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	103.96	22.97	9.94	1.34	2.55	1.48	0.13	1.61	0.27	18.27
signet ring carcinoma cell line:Kato III	10436-106E4	59.46	47.97	6.30	2.32	5.08	0.88	0.55	1.11	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	78.32	46.06	12.39	3.48	4.77	2.84	1.03	0.52	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	57.46	64.55	1.42	3.55	4.97	1.42	0.00	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	104.83	65.85	3.36	1.92	3.84	0.96	1.08	1.56	0.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	42.21	22.11	3.02	2.01	2.01	1.01	2.01	0.00	4.02	0.00
skin, adult, donor1	10074-102A2	27.14	54.28	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	43.55	41.03	2.52	1.89	1.26	1.26	4.42	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	151.75	84.38	7.00	6.34	6.67	1.67	1.33	1.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	70.61	51.06	5.36	1.26	3.78	1.58	1.58	1.58	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	99.27	53.58	0.58	3.08	2.31	4.43	5.20	2.12	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	196.47	75.66	11.87	6.92	6.92	1.81	0.82	2.64	1.15	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	177.90	36.83	3.22	0.48	1.61	0.32	0.32	2.09	1.45	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	83.24	99.15	5.67	6.76	5.01	2.83	2.18	1.09	1.09	0.00
small intestine, adult, pool1	10024-101D6	123.15	75.85	7.05	4.90	3.34	2.15	2.27	0.84	0.60	0.00
small intestine, fetal, donor1	10064-101I1	69.04	106.14	2.70	5.16	5.90	3.69	2.46	0.98	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	64.11	21.03	4.62	1.54	1.03	1.54	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	79.35	72.88	0.78	1.29	1.55	2.33	1.81	1.03	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	123.56	220.85	2.14	9.11	2.14	0.80	0.54	0.27	2.95	0.00
spinal cord - adult, donor10196	10181-103D1	60.79	75.93	2.98	3.44	5.74	1.38	1.61	0.69	3.44	0.23
spinal cord, adult, donor10252	10159-103A6	94.62	59.93	1.58	0.79	1.97	1.97	0.79	1.18	1.97	0.39
spinal cord, adult, donor10258	10369-105F9	22.83	46.35	2.08	2.77	2.08	1.38	0.00	0.69	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	58.54	56.71	1.83	3.66	6.10	2.44	1.22	1.22	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	47.76	33.98	3.21	1.84	1.84	0.46	0.46	0.92	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	83.34	68.25	7.02	4.18	2.54	1.34	0.60	0.75	0.45	0.00
spleen, adult, pool1	10025-101D7	106.72	64.65	7.05	2.64	2.31	1.65	1.21	1.43	0.33	0.00
spleen, fetal, pool1	10044-101F8	108.77	60.15	4.93	3.02	2.78	2.54	2.07	1.51	1.19	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	96.16	43.58	18.63	4.14	7.87	1.04	0.83	1.76	0.21	4.55
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	81.27	31.52	3.04	0.57	2.47	0.38	0.57	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	86.66	60.80	4.89	2.10	3.15	3.15	2.10	1.05	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	125.10	90.31	12.12	5.86	3.13	1.95	0.78	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	137.77	66.30	8.78	4.61	1.91	1.80	0.90	2.59	0.79	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	143.18	67.78	8.05	5.08	2.12	5.93	1.69	0.85	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	91.81	12.27	12.69	3.38	1.69	1.27	0.85	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	91.85	275.54	4.27	11.75	11.75	3.20	4.27	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	58.68	52.41	3.42	3.42	1.14	1.14	1.14	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	325.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	95.96	62.10	3.74	5.82	4.78	1.25	1.25	1.87	1.45	0.21
substantia nigra, adult, donor10258	10371-105G2	64.66	83.79	1.55	1.03	4.14	2.59	0.00	2.07	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	63.59	50.87	2.83	3.53	4.24	2.83	0.00	1.41	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	40.81	43.33	4.13	3.67	1.15	2.52	1.60	1.60	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	147.25	69.94	5.68	3.73	3.31	0.93	0.51	2.80	2.88	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	74.08	117.52	1.42	4.99	2.14	4.27	2.85	2.14	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	84.39	93.18	1.76	4.40	2.20	3.08	0.88	4.40	2.20	0.00
tenocyte, donor1	11763-123H8	66.33	45.03	1.75	3.84	1.05	3.49	2.44	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	59.90	36.62	1.53	4.96	2.29	1.14	1.14	0.76	0.38	0.00
tenocyte, donor3	11768-123I4	72.28	31.88	1.85	0.74	1.85	3.34	0.74	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	308.31	155.00	29.74	11.90	20.23	8.16	3.23	5.27	1.70	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	137.65	99.58	4.93	7.71	5.09	4.78	1.23	2.31	0.77	0.00
teratocarcinoma cell line:PA-1	10807-111A6	185.82	72.53	9.92	4.18	4.96	0.62	0.93	2.63	0.62	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	113.36	66.65	14.85	5.97	4.44	2.29	1.78	1.14	1.52	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	97.57	84.71	4.54	2.65	4.16	0.38	1.13	2.27	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	198.38	79.83	12.76	4.14	8.51	2.73	2.07	0.55	0.55	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	81.10	57.32	5.86	2.28	3.26	1.95	0.65	2.28	1.30	0.00
testis, adult, pool1	10026-101D8	119.29	124.44	3.76	3.87	4.08	3.22	2.90	8.70	42.95	0.75
testis, adult, pool2	10096-102C6	127.66	246.74	3.16	5.41	9.02	3.61	0.90	11.73	80.74	0.00
thalamus - adult, donor10196	10168-103B6	69.55	87.21	3.31	4.42	2.21	2.21	1.10	0.00	2.21	0.00
thalamus, adult, donor10252	10154-103A1	105.65	63.92	2.66	3.75	3.13	1.41	0.31	2.34	2.81	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	106.23	1.54	0.00	3.08	0.00	0.00	3.08	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	60.61	67.36	1.48	3.95	3.46	1.65	1.32	1.98	1.65	0.00
thalamus, newborn, donor10223	10366-105F6	48.90	31.64	8.05	2.88	5.18	1.15	1.15	1.73	0.58	0.00
throat, adult	10209-103G2	68.16	44.69	4.24	2.25	2.75	1.75	1.50	0.25	0.50	0.25
throat, fetal, donor1	10061-101H7	59.72	92.33	1.22	2.74	3.96	3.96	1.52	0.61	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	93.40	63.59	0.99	4.77	1.39	7.95	4.57	0.99	0.00	0.00
thymus, adult, pool1	10027-101D9	173.98	148.23	5.47	9.15	4.77	3.68	3.58	5.57	0.99	0.00
thymus, fetal, pool1	10043-101F7	181.11	104.84	4.05	7.59	2.60	4.05	3.01	4.36	0.52	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	146.52	76.05	14.36	3.99	3.99	1.86	1.73	1.20	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	133.40	93.73	7.12	5.59	4.05	0.84	1.40	0.98	0.14	0.00
thyroid, adult, pool1	10028-101E1	101.99	68.40	3.17	2.89	2.33	2.43	1.87	0.93	1.03	0.00
thyroid, fetal, donor1	10060-101H6	53.79	106.52	0.26	4.48	4.48	3.95	2.11	0.53	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	101.63	6.16	3.08	6.16	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	78.15	36.51	4.65	2.56	3.49	1.40	0.93	1.63	0.93	0.00
tongue, fetal, donor1	10059-101H5	88.67	89.85	3.15	4.34	6.70	3.55	2.76	0.79	0.79	0.00
tonsil, adult, pool1	10047-101G2	159.58	83.35	13.42	5.11	3.91	2.40	1.40	1.90	0.70	0.00
trachea, adult, pool1	10029-101E2	88.10	52.11	3.93	2.62	1.72	1.55	0.98	0.65	0.41	0.00
trachea, fetal, donor1	10058-101H4	39.62	41.55	1.15	3.85	1.92	1.92	1.54	1.92	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	87.86	43.22	9.92	3.90	3.19	1.06	1.42	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	124.11	56.64	8.92	4.76	3.34	0.91	1.11	1.62	0.61	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	120.65	60.48	4.07	1.72	1.72	2.66	1.41	0.94	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	81.81	123.66	5.71	7.61	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	113.77	36.40	4.91	2.79	3.47	2.45	1.27	0.42	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	52.16	77.20	0.00	2.09	0.00	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	110.57	71.32	1.54	0.85	1.88	3.41	1.71	0.85	1.19	8.87
uterus, fetal, donor1	10055-101H1	44.03	51.70	1.02	3.07	1.54	4.61	3.07	0.00	0.51	25.60
vagina, adult	10204-103F6	102.10	42.65	0.00	4.52	0.65	0.00	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	69.49	56.33	3.73	5.92	3.95	1.10	1.53	1.97	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	102.28	53.41	5.07	4.54	3.20	1.60	1.87	0.27	0.27	0.00